Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF711
|
ENSG00000147180.12 | zinc finger protein 711 |
TFAP2A
|
ENSG00000137203.6 | transcription factor AP-2 alpha |
TFAP2D
|
ENSG00000008197.4 | transcription factor AP-2 delta |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_10417099_10417355 | TFAP2A | 804 | 0.580863 | 0.88 | 1.6e-03 | Click! |
chr6_10404150_10404402 | TFAP2A | 551 | 0.759810 | 0.86 | 2.9e-03 | Click! |
chr6_10417444_10417667 | TFAP2A | 1132 | 0.451442 | 0.84 | 4.9e-03 | Click! |
chr6_10405106_10405257 | TFAP2A | 354 | 0.868193 | 0.84 | 4.9e-03 | Click! |
chr6_10416807_10416958 | TFAP2A | 459 | 0.776390 | 0.80 | 9.8e-03 | Click! |
chrX_84499397_84499548 | ZNF711 | 299 | 0.567413 | 0.70 | 3.5e-02 | Click! |
chrX_84498792_84498943 | ZNF711 | 130 | 0.651720 | 0.42 | 2.6e-01 | Click! |
chrX_84501522_84501673 | ZNF711 | 1826 | 0.367116 | 0.41 | 2.8e-01 | Click! |
chrX_84499808_84499973 | ZNF711 | 119 | 0.923158 | 0.32 | 4.1e-01 | Click! |
chrX_84500652_84500803 | ZNF711 | 956 | 0.536927 | 0.16 | 6.8e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_176857919_176858519 | 5.63 |
GRK6 |
G protein-coupled receptor kinase 6 |
4364 |
0.11 |
chr17_72984009_72984428 | 5.39 |
CDR2L |
cerebellar degeneration-related protein 2-like |
491 |
0.63 |
chr1_27683765_27684109 | 5.37 |
MAP3K6 |
mitogen-activated protein kinase kinase kinase 6 |
975 |
0.41 |
chr3_47028644_47028882 | 5.29 |
CCDC12 |
coiled-coil domain containing 12 |
5291 |
0.19 |
chr19_2057508_2057727 | 5.23 |
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
6374 |
0.11 |
chr10_8092737_8093024 | 5.20 |
GATA3 |
GATA binding protein 3 |
3776 |
0.37 |
chr1_203044798_203045050 | 5.18 |
MYOG |
myogenin (myogenic factor 4) |
10240 |
0.13 |
chr1_204430287_204430899 | 5.07 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
5881 |
0.2 |
chr20_61407593_61408050 | 5.03 |
LINC00659 |
long intergenic non-protein coding RNA 659 |
1057 |
0.39 |
chr8_144655209_144655539 | 5.00 |
MROH6 |
maestro heat-like repeat family member 6 |
233 |
0.51 |
chr10_126315803_126316294 | 4.96 |
FAM53B-AS1 |
FAM53B antisense RNA 1 |
76146 |
0.09 |
chr3_129325066_129325247 | 4.94 |
PLXND1 |
plexin D1 |
505 |
0.77 |
chr12_133005903_133006259 | 4.94 |
MUC8 |
mucin 8 |
44645 |
0.14 |
chr8_13133548_13134103 | 4.84 |
DLC1 |
deleted in liver cancer 1 |
230 |
0.96 |
chr9_135932298_135932581 | 4.84 |
GTF3C5 |
general transcription factor IIIC, polypeptide 5, 63kDa |
3133 |
0.17 |
chr11_613893_614044 | 4.84 |
IRF7 |
interferon regulatory factor 7 |
1658 |
0.18 |
chr1_182360343_182360566 | 4.81 |
GLUL |
glutamate-ammonia ligase |
85 |
0.97 |
chr11_73098997_73099258 | 4.70 |
RP11-809N8.2 |
|
8354 |
0.15 |
chr10_70166213_70166490 | 4.68 |
RUFY2 |
RUN and FYVE domain containing 2 |
595 |
0.72 |
chr22_39268574_39268744 | 4.61 |
CBX6 |
chromobox homolog 6 |
340 |
0.85 |
chr2_121493910_121494153 | 4.47 |
GLI2 |
GLI family zinc finger 2 |
208 |
0.97 |
chr12_52208271_52208474 | 4.40 |
AC068987.1 |
HCG1997999; cDNA FLJ33996 fis, clone DFNES2008881 |
4583 |
0.25 |
chr1_29450884_29451169 | 4.38 |
TMEM200B |
transmembrane protein 200B |
579 |
0.76 |
chr15_77307068_77307417 | 4.38 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
910 |
0.6 |
chr1_46768371_46768582 | 4.30 |
LRRC41 |
leucine rich repeat containing 41 |
804 |
0.38 |
chr16_403840_404259 | 4.30 |
AXIN1 |
axin 1 |
1390 |
0.27 |
chr10_8103926_8104304 | 4.27 |
GATA3 |
GATA binding protein 3 |
7346 |
0.33 |
chr11_1865277_1865556 | 4.27 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
3992 |
0.11 |
chr1_200989461_200990085 | 4.25 |
KIF21B |
kinesin family member 21B |
2763 |
0.26 |
chr11_63754209_63754360 | 4.24 |
OTUB1 |
OTU domain, ubiquitin aldehyde binding 1 |
30 |
0.96 |
chr9_137533446_137533714 | 4.20 |
COL5A1 |
collagen, type V, alpha 1 |
40 |
0.98 |
chr17_38600137_38600500 | 4.18 |
IGFBP4 |
insulin-like growth factor binding protein 4 |
605 |
0.66 |
chr1_2431041_2431419 | 4.17 |
RP3-395M20.3 |
|
5312 |
0.11 |
chr21_36261355_36261575 | 4.17 |
RUNX1 |
runt-related transcription factor 1 |
478 |
0.89 |
chrX_132092122_132092387 | 4.15 |
HS6ST2 |
heparan sulfate 6-O-sulfotransferase 2 |
910 |
0.71 |
chr22_47171835_47172134 | 4.13 |
TBC1D22A |
TBC1 domain family, member 22A |
2160 |
0.31 |
chr4_7654083_7654234 | 4.11 |
SORCS2 |
sortilin-related VPS10 domain containing receptor 2 |
81849 |
0.1 |
chr5_121412901_121413399 | 4.11 |
LOX |
lysyl oxidase |
830 |
0.68 |
chr12_4257673_4258417 | 4.10 |
CCND2 |
cyclin D2 |
124893 |
0.05 |
chr2_177502578_177502729 | 4.08 |
ENSG00000252027 |
. |
26751 |
0.25 |
chr12_118541417_118541600 | 4.06 |
VSIG10 |
V-set and immunoglobulin domain containing 10 |
201 |
0.94 |
chr2_168149161_168149312 | 4.02 |
XIRP2 |
xin actin-binding repeat containing 2 |
105443 |
0.08 |
chr7_138720207_138720441 | 3.97 |
ZC3HAV1L |
zinc finger CCCH-type, antiviral 1-like |
451 |
0.85 |
chr19_39369157_39369690 | 3.96 |
RINL |
Ras and Rab interactor-like |
504 |
0.57 |
chr18_47721158_47721348 | 3.92 |
MYO5B |
myosin VB |
210 |
0.94 |
chr11_61100062_61100329 | 3.92 |
DDB1 |
damage-specific DNA binding protein 1, 127kDa |
112 |
0.84 |
chr8_142426082_142426268 | 3.92 |
PTP4A3 |
protein tyrosine phosphatase type IVA, member 3 |
5832 |
0.14 |
chr10_134259846_134259997 | 3.91 |
C10orf91 |
chromosome 10 open reading frame 91 |
1228 |
0.45 |
chr14_75078606_75078757 | 3.87 |
LTBP2 |
latent transforming growth factor beta binding protein 2 |
94 |
0.97 |
chr14_105540960_105541139 | 3.87 |
GPR132 |
G protein-coupled receptor 132 |
9267 |
0.19 |
chr19_1566771_1567054 | 3.87 |
MEX3D |
mex-3 RNA binding family member D |
617 |
0.49 |
chr19_1854341_1854539 | 3.85 |
CTB-31O20.6 |
|
2042 |
0.15 |
chr14_104337931_104338272 | 3.85 |
PPP1R13B |
protein phosphatase 1, regulatory subunit 13B |
24174 |
0.14 |
chr11_61583176_61583333 | 3.84 |
FADS1 |
fatty acid desaturase 1 |
326 |
0.46 |
chr11_44970987_44971166 | 3.84 |
TP53I11 |
tumor protein p53 inducible protein 11 |
635 |
0.8 |
chr2_65657930_65658320 | 3.83 |
SPRED2 |
sprouty-related, EVH1 domain containing 2 |
1186 |
0.57 |
chr16_2264482_2264638 | 3.81 |
PGP |
phosphoglycolate phosphatase |
248 |
0.75 |
chr15_73344221_73344400 | 3.77 |
NEO1 |
neogenin 1 |
259 |
0.96 |
chr17_76121997_76122236 | 3.75 |
TMC6 |
transmembrane channel-like 6 |
985 |
0.4 |
chr1_154980060_154980211 | 3.74 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
4840 |
0.08 |
chr15_83316226_83316466 | 3.73 |
CPEB1 |
cytoplasmic polyadenylation element binding protein 1 |
10 |
0.69 |
chr5_175959848_175960395 | 3.73 |
RNF44 |
ring finger protein 44 |
2475 |
0.19 |
chr7_2549746_2549971 | 3.73 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
2305 |
0.25 |
chr21_45586061_45586359 | 3.71 |
AP001055.1 |
|
7370 |
0.15 |
chr5_133984728_133984879 | 3.69 |
SAR1B |
SAR1 homolog B (S. cerevisiae) |
158 |
0.66 |
chr10_31609488_31609880 | 3.68 |
ENSG00000237036 |
. |
308 |
0.56 |
chr17_76310134_76310416 | 3.68 |
SOCS3 |
suppressor of cytokine signaling 3 |
45880 |
0.1 |
chr11_1859254_1859405 | 3.68 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
890 |
0.39 |
chr16_57166336_57166595 | 3.67 |
CPNE2 |
copine II |
13354 |
0.14 |
chr2_127863797_127864053 | 3.66 |
BIN1 |
bridging integrator 1 |
652 |
0.79 |
chr22_46957837_46957988 | 3.66 |
GRAMD4 |
GRAM domain containing 4 |
13997 |
0.18 |
chr7_19156075_19156556 | 3.64 |
TWIST1 |
twist family bHLH transcription factor 1 |
980 |
0.47 |
chr6_75915740_75915921 | 3.62 |
COL12A1 |
collagen, type XII, alpha 1 |
63 |
0.98 |
chr2_12857216_12857660 | 3.60 |
TRIB2 |
tribbles pseudokinase 2 |
377 |
0.91 |
chr7_2549413_2549701 | 3.59 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
2606 |
0.23 |
chr5_322140_322309 | 3.56 |
AHRR |
aryl-hydrocarbon receptor repressor |
350 |
0.87 |
chr4_123843627_123843810 | 3.56 |
NUDT6 |
nudix (nucleoside diphosphate linked moiety X)-type motif 6 |
43 |
0.9 |
chr16_1401418_1401569 | 3.55 |
TSR3 |
TSR3, 20S rRNA accumulation, homolog (S. cerevisiae) |
419 |
0.41 |
chr1_156084846_156085321 | 3.54 |
LMNA |
lamin A/C |
570 |
0.62 |
chr19_1252428_1252628 | 3.54 |
MIDN |
midnolin |
907 |
0.35 |
chr1_2518671_2518922 | 3.52 |
FAM213B |
family with sequence similarity 213, member B |
480 |
0.67 |
chr22_20051623_20051921 | 3.51 |
AC006547.15 |
|
1456 |
0.19 |
chr9_138999867_139000258 | 3.50 |
C9orf69 |
chromosome 9 open reading frame 69 |
10058 |
0.19 |
chr14_104605026_104605308 | 3.50 |
KIF26A |
kinesin family member 26A |
107 |
0.93 |
chr2_45236571_45236881 | 3.49 |
SIX2 |
SIX homeobox 2 |
157 |
0.97 |
chr11_507502_507804 | 3.49 |
RNH1 |
ribonuclease/angiogenin inhibitor 1 |
353 |
0.74 |
chr22_50984494_50984645 | 3.46 |
CTA-384D8.31 |
|
275 |
0.75 |
chr6_5085493_5085788 | 3.45 |
PPP1R3G |
protein phosphatase 1, regulatory subunit 3G |
80 |
0.98 |
chr2_28837383_28837544 | 3.44 |
PLB1 |
phospholipase B1 |
12677 |
0.21 |
chr11_1873282_1874046 | 3.44 |
LSP1 |
lymphocyte-specific protein 1 |
536 |
0.61 |
chr9_127266331_127266670 | 3.43 |
NR5A1 |
nuclear receptor subfamily 5, group A, member 1 |
3014 |
0.28 |
chr12_52214398_52214604 | 3.43 |
AC068987.1 |
HCG1997999; cDNA FLJ33996 fis, clone DFNES2008881 |
10712 |
0.21 |
chr1_20960269_20960420 | 3.42 |
PINK1 |
PTEN induced putative kinase 1 |
396 |
0.84 |
chr22_50453000_50453188 | 3.42 |
IL17REL |
interleukin 17 receptor E-like |
2006 |
0.3 |
chr18_77161709_77162041 | 3.39 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
1483 |
0.49 |
chr5_175956521_175957004 | 3.39 |
RNF44 |
ring finger protein 44 |
884 |
0.47 |
chr1_156552148_156552452 | 3.37 |
TTC24 |
tetratricopeptide repeat domain 24 |
1143 |
0.29 |
chr17_42386389_42386620 | 3.36 |
RUNDC3A |
RUN domain containing 3A |
540 |
0.42 |
chr5_129239898_129240062 | 3.35 |
CHSY3 |
chondroitin sulfate synthase 3 |
185 |
0.93 |
chr10_119303450_119303630 | 3.35 |
EMX2 |
empty spiracles homeobox 2 |
1031 |
0.41 |
chr17_41738370_41738709 | 3.35 |
MEOX1 |
mesenchyme homeobox 1 |
392 |
0.85 |
chr17_72595359_72595719 | 3.34 |
CD300LD |
CD300 molecule-like family member d |
7117 |
0.13 |
chr4_141490140_141490356 | 3.34 |
UCP1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
289 |
0.9 |
chr1_206910364_206910608 | 3.33 |
ENSG00000199349 |
. |
10951 |
0.16 |
chr3_10206692_10206843 | 3.33 |
IRAK2 |
interleukin-1 receptor-associated kinase 2 |
218 |
0.89 |
chr8_145004565_145004907 | 3.33 |
PLEC |
plectin |
3557 |
0.14 |
chr1_117113459_117113610 | 3.32 |
CD58 |
CD58 molecule |
114 |
0.96 |
chr10_134230917_134231313 | 3.32 |
PWWP2B |
PWWP domain containing 2B |
20413 |
0.16 |
chr17_75243284_75243621 | 3.30 |
SEPT9 |
septin 9 |
33199 |
0.16 |
chr17_1531388_1531591 | 3.30 |
SLC43A2 |
solute carrier family 43 (amino acid system L transporter), member 2 |
146 |
0.92 |
chr1_1149625_1149876 | 3.29 |
TNFRSF4 |
tumor necrosis factor receptor superfamily, member 4 |
238 |
0.82 |
chr22_19710642_19710976 | 3.29 |
GP1BB |
glycoprotein Ib (platelet), beta polypeptide |
341 |
0.86 |
chr7_40174834_40175089 | 3.29 |
SUGCT |
succinylCoA:glutarate-CoA transferase |
342 |
0.72 |
chr19_49971612_49971929 | 3.29 |
FLT3LG |
fms-related tyrosine kinase 3 ligand |
5715 |
0.06 |
chr1_53386842_53387121 | 3.29 |
ECHDC2 |
enoyl CoA hydratase domain containing 2 |
395 |
0.76 |
chr16_89992493_89992644 | 3.29 |
TUBB3 |
Tubulin beta-3 chain |
2794 |
0.15 |
chr9_134127671_134127998 | 3.29 |
FAM78A |
family with sequence similarity 78, member A |
18046 |
0.15 |
chr6_37666285_37666474 | 3.29 |
MDGA1 |
MAM domain containing glycosylphosphatidylinositol anchor 1 |
613 |
0.81 |
chr16_81580791_81581171 | 3.28 |
CMIP |
c-Maf inducing protein |
52027 |
0.16 |
chr11_2320203_2320640 | 3.27 |
C11orf21 |
chromosome 11 open reading frame 21 |
2722 |
0.17 |
chr17_19770414_19770638 | 3.27 |
ULK2 |
unc-51 like autophagy activating kinase 2 |
704 |
0.71 |
chr19_2041246_2041591 | 3.27 |
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
212 |
0.88 |
chr21_45592812_45592963 | 3.27 |
AP001055.1 |
|
693 |
0.61 |
chr11_63656801_63657461 | 3.27 |
MARK2 |
MAP/microtubule affinity-regulating kinase 2 |
963 |
0.45 |
chr1_9687682_9687977 | 3.27 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
23961 |
0.14 |
chr11_1864039_1864323 | 3.26 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
2757 |
0.14 |
chr16_30406488_30406639 | 3.25 |
ZNF48 |
zinc finger protein 48 |
130 |
0.9 |
chr19_2041628_2041930 | 3.24 |
MKNK2 |
MAP kinase interacting serine/threonine kinase 2 |
302 |
0.81 |
chr14_103524228_103524440 | 3.23 |
CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
535 |
0.77 |
chr10_71390210_71390493 | 3.23 |
C10orf35 |
chromosome 10 open reading frame 35 |
51 |
0.98 |
chr21_46327269_46327513 | 3.23 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
3154 |
0.15 |
chr2_177053184_177053381 | 3.22 |
HOXD-AS1 |
HOXD cluster antisense RNA 1 |
14 |
0.49 |
chr11_1970690_1970922 | 3.21 |
MRPL23 |
mitochondrial ribosomal protein L23 |
2232 |
0.2 |
chr2_220312999_220313150 | 3.20 |
SPEG |
SPEG complex locus |
3695 |
0.12 |
chr15_41787317_41787589 | 3.20 |
ITPKA |
inositol-trisphosphate 3-kinase A |
1380 |
0.33 |
chr2_204399499_204399690 | 3.19 |
RAPH1 |
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 |
391 |
0.91 |
chr1_61549055_61549206 | 3.19 |
ENSG00000263380 |
. |
72 |
0.93 |
chr9_88713988_88714176 | 3.19 |
GOLM1 |
golgi membrane protein 1 |
391 |
0.92 |
chr17_55059842_55059993 | 3.18 |
RP5-1107A17.4 |
|
193 |
0.91 |
chr17_29822059_29822344 | 3.18 |
RAB11FIP4 |
RAB11 family interacting protein 4 (class II) |
7075 |
0.14 |
chr14_23451353_23451733 | 3.18 |
AJUBA |
ajuba LIM protein |
4 |
0.5 |
chr12_63328126_63328277 | 3.17 |
PPM1H |
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
616 |
0.66 |
chr2_233945441_233945945 | 3.17 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
20504 |
0.18 |
chr22_23583322_23583546 | 3.16 |
BCR |
breakpoint cluster region |
12713 |
0.16 |
chr17_72787457_72787723 | 3.16 |
TMEM104 |
transmembrane protein 104 |
14931 |
0.1 |
chr19_33789917_33790563 | 3.16 |
CTD-2540B15.11 |
|
600 |
0.59 |
chr22_24819662_24819813 | 3.16 |
ADORA2A |
adenosine A2a receptor |
138 |
0.96 |
chr2_47796675_47797093 | 3.15 |
KCNK12 |
potassium channel, subfamily K, member 12 |
1194 |
0.44 |
chr7_2749048_2749199 | 3.15 |
AMZ1 |
archaelysin family metallopeptidase 1 |
21287 |
0.19 |
chr8_144655938_144656162 | 3.14 |
RP11-661A12.9 |
|
390 |
0.57 |
chr2_216176953_216177104 | 3.14 |
ATIC |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
193 |
0.95 |
chr16_85678818_85679245 | 3.14 |
GSE1 |
Gse1 coiled-coil protein |
9007 |
0.17 |
chr14_100149825_100150149 | 3.14 |
CYP46A1 |
cytochrome P450, family 46, subfamily A, polypeptide 1 |
664 |
0.72 |
chr17_37250282_37250699 | 3.14 |
ENSG00000222494 |
. |
13172 |
0.14 |
chr8_38325731_38325987 | 3.13 |
FGFR1 |
fibroblast growth factor receptor 1 |
275 |
0.9 |
chr22_39763258_39763448 | 3.12 |
SYNGR1 |
synaptogyrin 1 |
3178 |
0.18 |
chr5_121413529_121413763 | 3.11 |
LOX |
lysyl oxidase |
334 |
0.91 |
chr20_50158757_50158998 | 3.11 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
381 |
0.92 |
chr16_67572091_67572242 | 3.11 |
FAM65A |
family with sequence similarity 65, member A |
185 |
0.86 |
chr11_44600925_44601210 | 3.11 |
CD82 |
CD82 molecule |
6439 |
0.22 |
chr22_20225336_20225601 | 3.11 |
RTN4R |
reticulon 4 receptor |
5739 |
0.14 |
chr19_8942675_8942826 | 3.10 |
ZNF558 |
zinc finger protein 558 |
254 |
0.53 |
chr12_7055006_7055369 | 3.10 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
444 |
0.5 |
chr10_73506063_73506340 | 3.10 |
C10orf105 |
chromosome 10 open reading frame 105 |
8620 |
0.2 |
chr10_74083419_74083604 | 3.10 |
DNAJB12 |
DnaJ (Hsp40) homolog, subfamily B, member 12 |
21208 |
0.16 |
chr21_45577023_45577427 | 3.09 |
AP001055.1 |
|
16355 |
0.13 |
chr17_40827970_40828303 | 3.09 |
PLEKHH3 |
pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 |
833 |
0.38 |
chr1_110611581_110611747 | 3.09 |
ALX3 |
ALX homeobox 3 |
1658 |
0.26 |
chr14_54413387_54413538 | 3.09 |
ENSG00000266431 |
. |
1740 |
0.43 |
chr22_20224860_20225035 | 3.08 |
RTN4R |
reticulon 4 receptor |
6260 |
0.14 |
chr9_137264075_137264301 | 3.08 |
ENSG00000263897 |
. |
7069 |
0.25 |
chr12_7067345_7067996 | 3.08 |
ENSG00000207713 |
. |
5192 |
0.06 |
chr22_25003244_25003451 | 3.07 |
GGT1 |
gamma-glutamyltransferase 1 |
241 |
0.9 |
chr9_140201623_140201774 | 3.07 |
NRARP |
NOTCH-regulated ankyrin repeat protein |
4995 |
0.1 |
chr2_202507689_202507877 | 3.07 |
TMEM237 |
transmembrane protein 237 |
116 |
0.96 |
chr17_8907492_8907663 | 3.06 |
NTN1 |
netrin 1 |
17282 |
0.22 |
chr12_132991760_132991934 | 3.06 |
MUC8 |
mucin 8 |
58879 |
0.11 |
chr6_112574946_112575292 | 3.05 |
LAMA4 |
laminin, alpha 4 |
568 |
0.76 |
chr16_3006288_3006495 | 3.05 |
LA16c-321D4.2 |
|
2114 |
0.13 |
chr7_30188840_30189132 | 3.04 |
MTURN |
maturin, neural progenitor differentiation regulator homolog (Xenopus) |
3473 |
0.2 |
chr12_112563698_112563849 | 3.03 |
TRAFD1 |
TRAF-type zinc finger domain containing 1 |
406 |
0.8 |
chr15_47476608_47476882 | 3.02 |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
447 |
0.85 |
chrX_9434348_9434499 | 3.02 |
TBL1X |
transducin (beta)-like 1X-linked |
1089 |
0.69 |
chr19_10663855_10664009 | 3.01 |
ENSG00000221410 |
. |
1134 |
0.23 |
chr20_24299668_24299843 | 3.01 |
ENSG00000200231 |
. |
81864 |
0.11 |
chr2_91777481_91777632 | 3.01 |
AC027612.6 |
|
65973 |
0.12 |
chr6_132272068_132272363 | 3.01 |
RP11-69I8.3 |
|
129 |
0.72 |
chr21_45562741_45563043 | 3.00 |
C21orf33 |
chromosome 21 open reading frame 33 |
6891 |
0.16 |
chr11_120381906_120382148 | 3.00 |
GRIK4 |
glutamate receptor, ionotropic, kainate 4 |
441 |
0.5 |
chr10_72972706_72972878 | 3.00 |
UNC5B |
unc-5 homolog B (C. elegans) |
108 |
0.96 |
chr16_85368819_85368979 | 2.99 |
RP11-680G10.1 |
Uncharacterized protein |
22170 |
0.2 |
chr9_140130654_140130853 | 2.99 |
TUBB4B |
tubulin, beta 4B class IVb |
4912 |
0.06 |
chr16_84401967_84402118 | 2.99 |
ATP2C2 |
ATPase, Ca++ transporting, type 2C, member 2 |
91 |
0.97 |
chr5_141703481_141703955 | 2.99 |
SPRY4 |
sprouty homolog 4 (Drosophila) |
29 |
0.97 |
chr11_67202322_67202473 | 2.98 |
AP003419.16 |
|
473 |
0.55 |
chr16_374596_375006 | 2.98 |
AXIN1 |
axin 1 |
27648 |
0.08 |
chr20_48993365_48993516 | 2.98 |
ENSG00000244376 |
. |
52580 |
0.14 |
chr13_95365226_95365377 | 2.98 |
SOX21 |
SRY (sex determining region Y)-box 21 |
912 |
0.62 |
chr9_38068361_38068574 | 2.98 |
SHB |
Src homology 2 domain containing adaptor protein B |
741 |
0.75 |
chr4_40057808_40058129 | 2.98 |
N4BP2 |
NEDD4 binding protein 2 |
478 |
0.8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
4.8 | 14.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
4.6 | 18.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
4.4 | 13.1 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
4.3 | 4.3 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
4.3 | 12.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
4.1 | 20.7 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
4.1 | 16.5 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
3.9 | 11.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.8 | 11.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
3.7 | 11.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
3.5 | 14.2 | GO:0032621 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
3.5 | 10.5 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
3.4 | 10.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
3.4 | 17.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
3.4 | 10.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
3.4 | 10.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
3.3 | 26.8 | GO:0007172 | signal complex assembly(GO:0007172) |
3.2 | 16.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
3.2 | 3.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
3.2 | 9.7 | GO:0001705 | ectoderm formation(GO:0001705) |
3.2 | 16.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
3.2 | 9.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
3.2 | 12.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
3.1 | 12.5 | GO:0000089 | mitotic metaphase(GO:0000089) |
3.1 | 18.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
3.1 | 9.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
3.0 | 6.1 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
3.0 | 9.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
3.0 | 8.9 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
2.9 | 5.9 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
2.9 | 2.9 | GO:0061054 | dermatome development(GO:0061054) |
2.9 | 2.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
2.9 | 8.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
2.8 | 8.5 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
2.8 | 8.5 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
2.8 | 5.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.8 | 8.4 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
2.8 | 8.4 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
2.8 | 13.9 | GO:0001553 | luteinization(GO:0001553) |
2.8 | 8.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
2.8 | 8.3 | GO:0043276 | anoikis(GO:0043276) |
2.8 | 8.3 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
2.7 | 13.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
2.7 | 8.2 | GO:0060242 | contact inhibition(GO:0060242) |
2.7 | 2.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
2.7 | 8.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.7 | 13.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.6 | 15.7 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
2.6 | 2.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
2.6 | 5.2 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
2.6 | 15.5 | GO:0046645 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
2.6 | 20.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
2.5 | 5.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
2.5 | 10.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.5 | 7.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
2.5 | 5.0 | GO:0060510 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
2.5 | 10.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
2.5 | 7.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.5 | 7.4 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
2.4 | 2.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
2.4 | 7.3 | GO:0051451 | myoblast migration(GO:0051451) |
2.4 | 7.3 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
2.4 | 2.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
2.4 | 9.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
2.4 | 9.5 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
2.4 | 11.9 | GO:0007097 | nuclear migration(GO:0007097) |
2.4 | 11.9 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
2.4 | 7.1 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
2.4 | 7.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
2.4 | 4.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
2.4 | 2.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
2.4 | 4.7 | GO:0030903 | notochord development(GO:0030903) |
2.4 | 11.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
2.3 | 14.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
2.3 | 4.6 | GO:0060437 | lung growth(GO:0060437) |
2.3 | 9.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
2.3 | 4.6 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
2.3 | 6.9 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
2.3 | 11.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
2.3 | 4.5 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
2.3 | 2.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
2.2 | 6.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
2.2 | 6.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
2.2 | 2.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
2.2 | 8.8 | GO:0018101 | protein citrullination(GO:0018101) |
2.2 | 11.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
2.2 | 4.4 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) |
2.2 | 8.7 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
2.2 | 6.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
2.2 | 8.7 | GO:0045061 | thymic T cell selection(GO:0045061) |
2.2 | 10.9 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
2.2 | 2.2 | GO:0010565 | regulation of cellular ketone metabolic process(GO:0010565) |
2.2 | 6.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.2 | 6.5 | GO:0006007 | glucose catabolic process(GO:0006007) |
2.2 | 2.2 | GO:0071503 | response to heparin(GO:0071503) |
2.2 | 4.3 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
2.2 | 6.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
2.2 | 10.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
2.1 | 4.3 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
2.1 | 2.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.1 | 2.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
2.1 | 6.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.1 | 2.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
2.1 | 10.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.1 | 2.1 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
2.1 | 6.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
2.1 | 4.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.1 | 16.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
2.1 | 2.1 | GO:0090009 | primitive streak formation(GO:0090009) |
2.1 | 6.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
2.1 | 6.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
2.1 | 6.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.1 | 2.1 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
2.1 | 2.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
2.1 | 6.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
2.1 | 2.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
2.1 | 8.2 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
2.1 | 2.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
2.0 | 6.1 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
2.0 | 4.1 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
2.0 | 12.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
2.0 | 4.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
2.0 | 2.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
2.0 | 4.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
2.0 | 6.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.0 | 20.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
2.0 | 6.0 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
2.0 | 22.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
2.0 | 2.0 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
2.0 | 2.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
2.0 | 8.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.0 | 2.0 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
2.0 | 2.0 | GO:0060235 | olfactory placode formation(GO:0030910) lens induction in camera-type eye(GO:0060235) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.0 | 2.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.0 | 2.0 | GO:0090286 | nuclear matrix organization(GO:0043578) cytoskeletal anchoring at nuclear membrane(GO:0090286) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.0 | 3.9 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
1.9 | 9.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
1.9 | 1.9 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
1.9 | 9.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.9 | 15.4 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
1.9 | 5.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.9 | 17.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.9 | 7.7 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
1.9 | 5.7 | GO:0010842 | retina layer formation(GO:0010842) |
1.9 | 5.7 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
1.9 | 9.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
1.9 | 7.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.9 | 5.7 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
1.9 | 5.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.9 | 7.5 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
1.9 | 3.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
1.9 | 3.7 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
1.9 | 1.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.9 | 11.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.9 | 7.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.8 | 5.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
1.8 | 1.8 | GO:0042326 | negative regulation of phosphorylation(GO:0042326) |
1.8 | 5.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.8 | 5.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.8 | 5.5 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
1.8 | 3.7 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
1.8 | 9.1 | GO:0033197 | response to vitamin E(GO:0033197) |
1.8 | 3.6 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
1.8 | 10.9 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
1.8 | 5.4 | GO:0042100 | B cell proliferation(GO:0042100) |
1.8 | 5.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
1.8 | 5.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
1.8 | 5.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
1.8 | 3.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.8 | 1.8 | GO:0044848 | biological phase(GO:0044848) |
1.8 | 5.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.7 | 8.7 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
1.7 | 8.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.7 | 5.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.7 | 6.9 | GO:0031579 | membrane raft organization(GO:0031579) |
1.7 | 6.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.7 | 6.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
1.7 | 35.9 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
1.7 | 3.4 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
1.7 | 5.1 | GO:0042634 | regulation of hair cycle(GO:0042634) |
1.7 | 6.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.7 | 5.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
1.7 | 5.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.7 | 3.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.7 | 16.9 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
1.7 | 1.7 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
1.7 | 5.0 | GO:0070295 | renal water absorption(GO:0070295) |
1.7 | 10.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.7 | 10.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
1.7 | 5.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
1.7 | 1.7 | GO:0060401 | cytosolic calcium ion transport(GO:0060401) |
1.7 | 5.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.7 | 11.6 | GO:0001782 | B cell homeostasis(GO:0001782) |
1.7 | 5.0 | GO:2001234 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
1.7 | 3.3 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
1.7 | 16.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.7 | 5.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
1.7 | 1.7 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
1.6 | 11.5 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.6 | 14.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
1.6 | 3.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.6 | 1.6 | GO:0072091 | regulation of stem cell proliferation(GO:0072091) |
1.6 | 3.3 | GO:0098602 | single organism cell adhesion(GO:0098602) |
1.6 | 6.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.6 | 1.6 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
1.6 | 1.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.6 | 3.3 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
1.6 | 4.9 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
1.6 | 4.9 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
1.6 | 11.3 | GO:0050957 | equilibrioception(GO:0050957) |
1.6 | 1.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.6 | 1.6 | GO:0019530 | taurine metabolic process(GO:0019530) |
1.6 | 11.2 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
1.6 | 1.6 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
1.6 | 3.2 | GO:0010159 | specification of organ position(GO:0010159) |
1.6 | 1.6 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
1.6 | 9.5 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
1.6 | 17.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
1.6 | 1.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.6 | 3.1 | GO:0006154 | adenosine catabolic process(GO:0006154) |
1.6 | 4.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
1.6 | 7.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
1.6 | 3.1 | GO:0032898 | neurotrophin production(GO:0032898) |
1.6 | 3.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
1.6 | 3.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.6 | 4.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.6 | 4.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.6 | 1.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
1.6 | 3.1 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
1.6 | 12.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.6 | 1.6 | GO:0015802 | basic amino acid transport(GO:0015802) |
1.6 | 3.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
1.6 | 10.9 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
1.6 | 1.6 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
1.6 | 9.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.5 | 4.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
1.5 | 6.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
1.5 | 9.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.5 | 6.2 | GO:0046618 | drug export(GO:0046618) |
1.5 | 7.7 | GO:0001570 | vasculogenesis(GO:0001570) |
1.5 | 1.5 | GO:0002913 | lymphocyte anergy(GO:0002249) T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
1.5 | 7.7 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
1.5 | 4.6 | GO:0045007 | depurination(GO:0045007) |
1.5 | 18.4 | GO:0031648 | protein destabilization(GO:0031648) |
1.5 | 3.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
1.5 | 1.5 | GO:0006325 | chromatin organization(GO:0006325) |
1.5 | 7.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
1.5 | 3.0 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
1.5 | 3.0 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.5 | 7.5 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
1.5 | 36.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.5 | 4.5 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
1.5 | 3.0 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) syncytium formation(GO:0006949) myoblast fusion(GO:0007520) |
1.5 | 1.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
1.5 | 6.0 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
1.5 | 4.5 | GO:0016322 | neuron remodeling(GO:0016322) |
1.5 | 10.4 | GO:0010288 | response to lead ion(GO:0010288) |
1.5 | 1.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
1.5 | 5.9 | GO:0008218 | bioluminescence(GO:0008218) |
1.5 | 1.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
1.5 | 8.9 | GO:0030878 | thyroid gland development(GO:0030878) |
1.5 | 4.4 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
1.5 | 7.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.5 | 3.0 | GO:0032060 | bleb assembly(GO:0032060) |
1.5 | 4.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
1.5 | 5.9 | GO:0001820 | serotonin secretion(GO:0001820) |
1.5 | 1.5 | GO:0022601 | menstrual cycle phase(GO:0022601) |
1.5 | 2.9 | GO:0032308 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) prostaglandin secretion(GO:0032310) |
1.5 | 14.7 | GO:0098927 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
1.5 | 4.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.5 | 4.4 | GO:0010586 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
1.5 | 5.8 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
1.5 | 4.4 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
1.5 | 11.7 | GO:0034311 | diol metabolic process(GO:0034311) |
1.5 | 2.9 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
1.5 | 7.3 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.4 | 4.3 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
1.4 | 2.9 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
1.4 | 7.2 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.4 | 1.4 | GO:2000316 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
1.4 | 1.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.4 | 2.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.4 | 2.9 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
1.4 | 5.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
1.4 | 8.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
1.4 | 2.9 | GO:0007144 | female meiosis I(GO:0007144) |
1.4 | 18.6 | GO:0097581 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
1.4 | 11.5 | GO:0006491 | N-glycan processing(GO:0006491) |
1.4 | 7.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
1.4 | 1.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.4 | 4.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
1.4 | 2.8 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
1.4 | 4.3 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
1.4 | 2.8 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.4 | 5.7 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
1.4 | 4.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
1.4 | 1.4 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
1.4 | 2.8 | GO:0033687 | osteoblast proliferation(GO:0033687) |
1.4 | 5.6 | GO:0000154 | rRNA modification(GO:0000154) |
1.4 | 1.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.4 | 5.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.4 | 1.4 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
1.4 | 2.8 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.4 | 1.4 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
1.4 | 1.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.4 | 9.7 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
1.4 | 1.4 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
1.4 | 9.7 | GO:0031670 | cellular response to nutrient(GO:0031670) |
1.4 | 5.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.4 | 1.4 | GO:0002507 | tolerance induction(GO:0002507) |
1.4 | 1.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) ketone body metabolic process(GO:1902224) |
1.4 | 2.8 | GO:0070670 | response to interleukin-4(GO:0070670) |
1.4 | 1.4 | GO:0017085 | response to insecticide(GO:0017085) |
1.4 | 4.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.4 | 4.1 | GO:1903309 | negative regulation of chromatin modification(GO:1903309) |
1.4 | 5.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.4 | 4.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
1.4 | 2.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
1.4 | 2.7 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
1.4 | 6.8 | GO:0031000 | response to caffeine(GO:0031000) |
1.4 | 9.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
1.4 | 1.4 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
1.4 | 4.1 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
1.4 | 1.4 | GO:0021602 | cranial nerve morphogenesis(GO:0021602) |
1.4 | 4.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
1.4 | 1.4 | GO:1903429 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
1.4 | 2.7 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
1.4 | 5.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.4 | 1.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.3 | 5.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
1.3 | 4.0 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
1.3 | 5.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.3 | 6.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.3 | 5.3 | GO:0008354 | germ cell migration(GO:0008354) |
1.3 | 5.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.3 | 2.7 | GO:0010043 | response to zinc ion(GO:0010043) |
1.3 | 28.0 | GO:0043487 | regulation of RNA stability(GO:0043487) |
1.3 | 1.3 | GO:0019042 | viral latency(GO:0019042) |
1.3 | 4.0 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
1.3 | 2.7 | GO:0021831 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) |
1.3 | 4.0 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
1.3 | 2.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.3 | 6.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
1.3 | 1.3 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
1.3 | 10.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
1.3 | 2.7 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
1.3 | 18.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
1.3 | 4.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) positive regulation of protein kinase A signaling(GO:0010739) |
1.3 | 7.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.3 | 4.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.3 | 15.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
1.3 | 3.9 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
1.3 | 7.9 | GO:0051567 | histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
1.3 | 3.9 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
1.3 | 7.9 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
1.3 | 3.9 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
1.3 | 5.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.3 | 3.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
1.3 | 10.5 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
1.3 | 3.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.3 | 2.6 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
1.3 | 11.7 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
1.3 | 9.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
1.3 | 14.3 | GO:0045730 | respiratory burst(GO:0045730) |
1.3 | 2.6 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
1.3 | 1.3 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
1.3 | 3.9 | GO:0014888 | striated muscle adaptation(GO:0014888) |
1.3 | 1.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
1.3 | 5.2 | GO:0001945 | lymph vessel development(GO:0001945) |
1.3 | 3.9 | GO:0045792 | negative regulation of cell size(GO:0045792) |
1.3 | 3.9 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
1.3 | 3.8 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.3 | 6.4 | GO:0051322 | anaphase(GO:0051322) |
1.3 | 2.6 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.3 | 3.8 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.3 | 1.3 | GO:0002467 | germinal center formation(GO:0002467) |
1.3 | 11.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.3 | 2.5 | GO:0006560 | proline metabolic process(GO:0006560) |
1.3 | 14.0 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
1.3 | 5.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.3 | 10.1 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
1.3 | 15.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
1.3 | 6.3 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.3 | 2.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
1.3 | 1.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
1.3 | 1.3 | GO:0097576 | vacuole fusion(GO:0097576) |
1.3 | 1.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
1.3 | 10.0 | GO:0032456 | endocytic recycling(GO:0032456) |
1.3 | 1.3 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
1.2 | 5.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
1.2 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.2 | 1.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
1.2 | 14.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
1.2 | 1.2 | GO:0002063 | chondrocyte development(GO:0002063) |
1.2 | 32.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
1.2 | 3.7 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
1.2 | 1.2 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.2 | 1.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
1.2 | 9.8 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
1.2 | 3.6 | GO:0098926 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
1.2 | 4.9 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.2 | 6.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
1.2 | 2.4 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
1.2 | 1.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
1.2 | 18.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
1.2 | 3.6 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
1.2 | 4.8 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
1.2 | 16.7 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
1.2 | 1.2 | GO:0046931 | pore complex assembly(GO:0046931) |
1.2 | 2.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.2 | 7.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
1.2 | 2.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
1.2 | 2.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.2 | 1.2 | GO:0002329 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
1.2 | 1.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
1.2 | 2.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
1.2 | 2.4 | GO:0051169 | nuclear transport(GO:0051169) |
1.2 | 1.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
1.2 | 5.9 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
1.2 | 3.5 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
1.2 | 7.1 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
1.2 | 7.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
1.2 | 2.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.2 | 8.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.2 | 2.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.2 | 1.2 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
1.2 | 1.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
1.2 | 14.0 | GO:0006541 | glutamine metabolic process(GO:0006541) |
1.2 | 2.3 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.2 | 7.0 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.2 | 4.7 | GO:0072079 | nephron tubule formation(GO:0072079) |
1.2 | 9.3 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
1.2 | 2.3 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.2 | 53.4 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
1.2 | 3.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.2 | 1.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
1.2 | 6.9 | GO:0045995 | regulation of embryonic development(GO:0045995) |
1.2 | 2.3 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
1.2 | 4.6 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
1.2 | 17.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.1 | 1.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
1.1 | 9.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.1 | 3.4 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
1.1 | 1.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
1.1 | 4.5 | GO:0032202 | telomere assembly(GO:0032202) |
1.1 | 1.1 | GO:0021604 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
1.1 | 1.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
1.1 | 3.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
1.1 | 1.1 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
1.1 | 7.9 | GO:0034111 | negative regulation of homotypic cell-cell adhesion(GO:0034111) |
1.1 | 10.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
1.1 | 5.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.1 | 6.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
1.1 | 2.2 | GO:0061387 | regulation of extent of cell growth(GO:0061387) |
1.1 | 18.0 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
1.1 | 4.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.1 | 5.6 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
1.1 | 2.2 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
1.1 | 1.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
1.1 | 14.5 | GO:0009309 | amine biosynthetic process(GO:0009309) |
1.1 | 1.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
1.1 | 4.5 | GO:0090224 | regulation of spindle organization(GO:0090224) |
1.1 | 27.8 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) |
1.1 | 4.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
1.1 | 1.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
1.1 | 3.3 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
1.1 | 2.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
1.1 | 2.2 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
1.1 | 4.4 | GO:0006415 | translational termination(GO:0006415) |
1.1 | 1.1 | GO:0042417 | dopamine metabolic process(GO:0042417) |
1.1 | 2.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
1.1 | 3.3 | GO:0009215 | purine deoxyribonucleotide metabolic process(GO:0009151) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) |
1.1 | 4.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
1.1 | 14.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.1 | 1.1 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
1.1 | 1.1 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
1.1 | 3.3 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
1.1 | 27.4 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) negative regulation of cell projection organization(GO:0031345) |
1.1 | 1.1 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.1 | 3.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.1 | 4.4 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
1.1 | 3.3 | GO:0022614 | membrane to membrane docking(GO:0022614) |
1.1 | 4.4 | GO:0060004 | reflex(GO:0060004) |
1.1 | 3.3 | GO:0032368 | regulation of lipid transport(GO:0032368) |
1.1 | 3.2 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
1.1 | 4.3 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
1.1 | 3.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
1.1 | 4.3 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
1.1 | 3.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.1 | 1.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.1 | 12.8 | GO:0016925 | protein sumoylation(GO:0016925) |
1.1 | 3.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.1 | 1.1 | GO:0021754 | facial nucleus development(GO:0021754) |
1.1 | 2.1 | GO:2000258 | negative regulation of protein processing(GO:0010955) negative regulation of complement activation(GO:0045916) negative regulation of protein maturation(GO:1903318) negative regulation of protein activation cascade(GO:2000258) |
1.1 | 3.2 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
1.1 | 5.3 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
1.1 | 2.1 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
1.1 | 3.2 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
1.1 | 6.4 | GO:0045116 | protein neddylation(GO:0045116) |
1.1 | 7.4 | GO:0015884 | folic acid transport(GO:0015884) |
1.1 | 3.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
1.1 | 2.1 | GO:0060438 | trachea development(GO:0060438) |
1.1 | 2.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
1.1 | 4.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.1 | 2.1 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
1.1 | 6.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.1 | 3.2 | GO:0006477 | protein sulfation(GO:0006477) |
1.1 | 5.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.1 | 6.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
1.1 | 5.3 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
1.1 | 46.4 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
1.1 | 7.4 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
1.1 | 1.1 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) positive regulation of killing of cells of other organism(GO:0051712) |
1.1 | 4.2 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
1.1 | 1.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
1.1 | 12.6 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
1.0 | 1.0 | GO:0070141 | apoptotic process involved in morphogenesis(GO:0060561) response to UV-A(GO:0070141) |
1.0 | 24.1 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
1.0 | 1.0 | GO:0006006 | glucose metabolic process(GO:0006006) |
1.0 | 1.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
1.0 | 7.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
1.0 | 4.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
1.0 | 3.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
1.0 | 1.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.0 | 7.3 | GO:0048536 | spleen development(GO:0048536) |
1.0 | 2.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
1.0 | 1.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
1.0 | 8.3 | GO:0010039 | response to iron ion(GO:0010039) |
1.0 | 7.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
1.0 | 3.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
1.0 | 3.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.0 | 20.6 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
1.0 | 14.4 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.0 | 3.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.0 | 4.1 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
1.0 | 4.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
1.0 | 1.0 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
1.0 | 1.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
1.0 | 4.1 | GO:0060287 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
1.0 | 4.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
1.0 | 2.0 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
1.0 | 2.0 | GO:0048103 | somatic stem cell division(GO:0048103) |
1.0 | 6.1 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
1.0 | 5.0 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.0 | 6.0 | GO:0016311 | dephosphorylation(GO:0016311) |
1.0 | 10.0 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.0 | 2.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.0 | 7.0 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
1.0 | 2.0 | GO:0072505 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
1.0 | 36.0 | GO:0007498 | mesoderm development(GO:0007498) |
1.0 | 11.0 | GO:0007032 | endosome organization(GO:0007032) |
1.0 | 12.0 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
1.0 | 12.0 | GO:0016180 | snRNA processing(GO:0016180) |
1.0 | 2.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
1.0 | 6.0 | GO:0008347 | glial cell migration(GO:0008347) |
1.0 | 3.0 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
1.0 | 5.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
1.0 | 1.0 | GO:0060592 | mammary gland formation(GO:0060592) mammary placode formation(GO:0060596) |
1.0 | 10.9 | GO:0030101 | natural killer cell activation(GO:0030101) |
1.0 | 2.0 | GO:0019835 | cytolysis(GO:0019835) |
1.0 | 4.0 | GO:0001881 | receptor recycling(GO:0001881) |
1.0 | 2.0 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.0 | 6.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.0 | 1.0 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
1.0 | 39.5 | GO:0006968 | cellular defense response(GO:0006968) |
1.0 | 4.9 | GO:0006983 | ER overload response(GO:0006983) |
1.0 | 3.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.0 | 4.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
1.0 | 5.9 | GO:0006538 | glutamate catabolic process(GO:0006538) |
1.0 | 1.0 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
1.0 | 7.9 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
1.0 | 2.0 | GO:0015711 | organic anion transport(GO:0015711) |
1.0 | 2.9 | GO:0001757 | somite specification(GO:0001757) |
1.0 | 1.0 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
1.0 | 1.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.0 | 1.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.0 | 14.6 | GO:0000080 | mitotic G1 phase(GO:0000080) |
1.0 | 3.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
1.0 | 3.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
1.0 | 4.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.0 | 1.9 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
1.0 | 1.9 | GO:0030261 | chromosome condensation(GO:0030261) |
1.0 | 4.8 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
1.0 | 1.9 | GO:0061053 | somite development(GO:0061053) |
1.0 | 1.0 | GO:0033198 | response to ATP(GO:0033198) |
1.0 | 1.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
1.0 | 1.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.0 | 4.8 | GO:0008356 | asymmetric cell division(GO:0008356) |
1.0 | 2.9 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
1.0 | 1.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
1.0 | 14.3 | GO:0007140 | male meiosis(GO:0007140) |
1.0 | 2.9 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
1.0 | 2.9 | GO:0007143 | female meiotic division(GO:0007143) |
1.0 | 1.9 | GO:0032071 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
1.0 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.9 | 2.8 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.9 | 2.8 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.9 | 0.9 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.9 | 1.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.9 | 2.8 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.9 | 2.8 | GO:0009648 | photoperiodism(GO:0009648) |
0.9 | 0.9 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.9 | 2.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.9 | 2.8 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 34.7 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.9 | 54.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.9 | 2.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 3.7 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.9 | 7.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.9 | 0.9 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.9 | 1.9 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.9 | 0.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.9 | 1.9 | GO:1904251 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.9 | 0.9 | GO:0051668 | localization within membrane(GO:0051668) |
0.9 | 0.9 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.9 | 1.9 | GO:0001878 | response to yeast(GO:0001878) |
0.9 | 2.8 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.9 | 12.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.9 | 1.9 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.9 | 0.9 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.9 | 3.7 | GO:0043543 | protein acetylation(GO:0006473) protein acylation(GO:0043543) |
0.9 | 2.8 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.9 | 2.8 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.9 | 0.9 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.9 | 2.8 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.9 | 3.7 | GO:0000462 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) cleavage involved in rRNA processing(GO:0000469) endonucleolytic cleavage involved in rRNA processing(GO:0000478) endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.9 | 1.8 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.9 | 7.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.9 | 0.9 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.9 | 0.9 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.9 | 1.8 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.9 | 9.1 | GO:0001709 | cell fate determination(GO:0001709) |
0.9 | 2.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.9 | 2.7 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.9 | 8.2 | GO:0006386 | transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
0.9 | 2.7 | GO:0071569 | protein ufmylation(GO:0071569) |
0.9 | 0.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.9 | 0.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.9 | 1.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.9 | 60.7 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.9 | 2.7 | GO:0030091 | protein repair(GO:0030091) |
0.9 | 1.8 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.9 | 11.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.9 | 3.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.9 | 1.8 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.9 | 5.4 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.9 | 2.7 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.9 | 101.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.9 | 3.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.9 | 13.3 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.9 | 2.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.9 | 30.8 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.9 | 3.5 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.9 | 16.7 | GO:0034249 | negative regulation of translation(GO:0017148) negative regulation of cellular amide metabolic process(GO:0034249) |
0.9 | 5.3 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.9 | 2.6 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.9 | 4.4 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.9 | 7.0 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.9 | 2.6 | GO:0007379 | segment specification(GO:0007379) |
0.9 | 0.9 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.9 | 9.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.9 | 0.9 | GO:0060294 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.9 | 13.8 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.9 | 2.6 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.9 | 1.7 | GO:0051138 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.9 | 2.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.9 | 0.9 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.9 | 12.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.9 | 3.4 | GO:0046173 | polyol biosynthetic process(GO:0046173) |
0.9 | 0.9 | GO:0010458 | exit from mitosis(GO:0010458) |
0.9 | 4.3 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.9 | 1.7 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.9 | 3.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.9 | 0.9 | GO:0042542 | response to hydrogen peroxide(GO:0042542) |
0.9 | 2.6 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.8 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.8 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.8 | 5.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.8 | 0.8 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.8 | 4.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.8 | 0.8 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.8 | 0.8 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.8 | 2.5 | GO:0008306 | associative learning(GO:0008306) |
0.8 | 1.7 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.8 | 6.7 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.8 | 3.3 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.8 | 0.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.8 | 8.3 | GO:0006414 | translational elongation(GO:0006414) |
0.8 | 5.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.8 | 6.6 | GO:0031100 | organ regeneration(GO:0031100) |
0.8 | 1.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.8 | 13.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.8 | 8.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.8 | 1.7 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.8 | 12.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.8 | 4.9 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.8 | 29.7 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.8 | 2.5 | GO:0007530 | sex determination(GO:0007530) |
0.8 | 8.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.8 | 3.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.8 | 3.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.8 | 24.6 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.8 | 3.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.8 | 4.9 | GO:0009650 | UV protection(GO:0009650) |
0.8 | 1.6 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.8 | 2.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.8 | 1.6 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.8 | 4.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.8 | 4.9 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.8 | 1.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.8 | 4.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.8 | 2.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.8 | 9.6 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.8 | 78.6 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.8 | 0.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.8 | 4.0 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.8 | 2.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.8 | 5.6 | GO:0051923 | sulfation(GO:0051923) |
0.8 | 3.2 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.8 | 1.6 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.8 | 0.8 | GO:0045165 | cell fate commitment(GO:0045165) |
0.8 | 3.2 | GO:0045214 | sarcomere organization(GO:0045214) |
0.8 | 4.0 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.8 | 5.6 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.8 | 0.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.8 | 0.8 | GO:0046949 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) fatty-acyl-CoA metabolic process(GO:0035337) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.8 | 2.4 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.8 | 2.4 | GO:0015853 | adenine transport(GO:0015853) |
0.8 | 2.4 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.8 | 53.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.8 | 12.6 | GO:0051329 | mitotic S phase(GO:0000084) mitotic interphase(GO:0051329) |
0.8 | 2.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.8 | 0.8 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.8 | 1.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.8 | 7.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.8 | 6.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.8 | 3.9 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.8 | 3.1 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.8 | 3.9 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.8 | 4.7 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.8 | 1.6 | GO:0015838 | quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.8 | 1.5 | GO:0032273 | positive regulation of protein polymerization(GO:0032273) |
0.8 | 1.5 | GO:0051608 | histamine transport(GO:0051608) |
0.8 | 3.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.8 | 2.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.8 | 1.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.8 | 1.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.8 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.8 | 0.8 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090100) |
0.8 | 1.5 | GO:0060174 | limb bud formation(GO:0060174) |
0.8 | 15.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.8 | 8.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.8 | 0.8 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
0.8 | 2.3 | GO:0032570 | response to progesterone(GO:0032570) |
0.8 | 3.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.8 | 3.0 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.8 | 4.6 | GO:0010165 | response to X-ray(GO:0010165) |
0.8 | 26.6 | GO:0006914 | autophagy(GO:0006914) |
0.8 | 7.6 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.8 | 2.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 6.1 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.8 | 2.3 | GO:0030217 | T cell differentiation(GO:0030217) |
0.8 | 3.8 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.8 | 2.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.8 | 1.5 | GO:0045618 | positive regulation of epidermal cell differentiation(GO:0045606) positive regulation of keratinocyte differentiation(GO:0045618) |
0.8 | 1.5 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
0.8 | 7.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.8 | 1.5 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.8 | 3.0 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.8 | 12.8 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.8 | 0.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.8 | 4.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.8 | 17.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.7 | 3.7 | GO:0031623 | receptor internalization(GO:0031623) |
0.7 | 5.2 | GO:0006241 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.7 | 0.7 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.7 | 3.0 | GO:0045006 | DNA deamination(GO:0045006) |
0.7 | 5.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 1.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.7 | 12.7 | GO:0019079 | viral genome replication(GO:0019079) |
0.7 | 13.4 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.7 | 8.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.7 | 0.7 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.7 | 1.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.7 | 14.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.7 | 0.7 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.7 | 9.6 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.7 | 3.7 | GO:0014070 | response to organic cyclic compound(GO:0014070) |
0.7 | 0.7 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.7 | 2.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.7 | 6.6 | GO:0042384 | cilium assembly(GO:0042384) |
0.7 | 23.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.7 | 18.9 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.7 | 0.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.7 | 10.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.7 | 1.5 | GO:0001302 | replicative cell aging(GO:0001302) |
0.7 | 1.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.7 | 2.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.7 | 9.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.7 | 1.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.7 | 3.6 | GO:0071345 | cellular response to cytokine stimulus(GO:0071345) |
0.7 | 1.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.7 | 1.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.7 | 2.2 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.7 | 2.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.7 | 1.4 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.7 | 5.0 | GO:0016575 | histone deacetylation(GO:0016575) |
0.7 | 1.4 | GO:0060896 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
0.7 | 0.7 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.7 | 7.1 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.7 | 1.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.7 | 11.4 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.7 | 2.1 | GO:0006833 | water transport(GO:0006833) |
0.7 | 2.8 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.7 | 1.4 | GO:0098727 | maintenance of cell number(GO:0098727) |
0.7 | 3.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.7 | 3.5 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) GTP metabolic process(GO:0046039) prosthetic group metabolic process(GO:0051189) |
0.7 | 3.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.7 | 26.8 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.7 | 15.5 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
0.7 | 0.7 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.7 | 14.7 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.7 | 22.4 | GO:0070252 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) actin-mediated cell contraction(GO:0070252) |
0.7 | 0.7 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.7 | 2.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.7 | 9.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.7 | 2.1 | GO:0042129 | regulation of T cell proliferation(GO:0042129) |
0.7 | 0.7 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.7 | 1.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.7 | 2.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.7 | 9.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.7 | 4.8 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.7 | 0.7 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) negative regulation of systemic arterial blood pressure(GO:0003085) |
0.7 | 13.8 | GO:0006413 | translational initiation(GO:0006413) |
0.7 | 2.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.7 | 2.1 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.7 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.7 | 0.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.7 | 4.1 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.7 | 2.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 1.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.7 | 2.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.7 | 1.4 | GO:0046323 | glucose import(GO:0046323) |
0.7 | 1.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.7 | 4.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.7 | 10.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.7 | 0.7 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.7 | 9.5 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.7 | 43.2 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.7 | 3.4 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.7 | 11.5 | GO:0001666 | response to hypoxia(GO:0001666) |
0.7 | 1.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.7 | 1.3 | GO:0070265 | necrotic cell death(GO:0070265) |
0.7 | 0.7 | GO:0051181 | cofactor transport(GO:0051181) |
0.7 | 3.4 | GO:0006476 | protein deacetylation(GO:0006476) protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
0.7 | 2.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.7 | 1.3 | GO:0001678 | cellular glucose homeostasis(GO:0001678) |
0.7 | 7.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.7 | 0.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.7 | 2.7 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.7 | 6.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.7 | 7.9 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.7 | 2.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.7 | 7.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.7 | 8.6 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.7 | 1.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 5.3 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.7 | 2.0 | GO:0042640 | anagen(GO:0042640) |
0.7 | 4.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.7 | 1.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.7 | 28.1 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.7 | 22.2 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.7 | 2.6 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.6 | 3.9 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.6 | 0.6 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.6 | 5.2 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.6 | 0.6 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.6 | 1.3 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.6 | 2.6 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.6 | 17.4 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.6 | 1.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.6 | 19.3 | GO:0051403 | stress-activated MAPK cascade(GO:0051403) |
0.6 | 1.3 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.6 | 7.0 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.6 | 1.9 | GO:0070727 | cellular macromolecule localization(GO:0070727) |
0.6 | 1.9 | GO:0009301 | snRNA transcription(GO:0009301) |
0.6 | 3.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.6 | 91.5 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.6 | 0.6 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.6 | 3.2 | GO:0002209 | behavioral defense response(GO:0002209) |
0.6 | 1.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 5.7 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.6 | 2.5 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.6 | 1.9 | GO:0007632 | visual behavior(GO:0007632) |
0.6 | 5.1 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.6 | 3.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.6 | 8.2 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.6 | 8.8 | GO:0007041 | lysosomal transport(GO:0007041) |
0.6 | 1.9 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.6 | 3.2 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.6 | 3.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.6 | 1.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.6 | 4.4 | GO:0021915 | neural tube development(GO:0021915) |
0.6 | 12.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.6 | 11.3 | GO:0070588 | calcium ion transmembrane transport(GO:0070588) |
0.6 | 30.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.6 | 8.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.6 | 1.9 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.6 | 1.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.6 | 2.5 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.6 | 26.7 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.6 | 0.6 | GO:0030916 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.6 | 1.9 | GO:0006862 | nucleotide transport(GO:0006862) |
0.6 | 3.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.6 | 2.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 0.6 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.6 | 1.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.6 | 11.1 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.6 | 0.6 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 1.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.6 | 2.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.6 | 4.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.6 | 0.6 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.6 | 6.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.6 | 1.2 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.6 | 0.6 | GO:0032105 | negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
0.6 | 3.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.6 | 0.6 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.6 | 1.2 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.6 | 0.6 | GO:2000351 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.6 | 3.0 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.6 | 3.6 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.6 | 1.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.6 | 0.6 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.6 | 3.0 | GO:1903322 | positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
0.6 | 0.6 | GO:0060428 | lung epithelium development(GO:0060428) |
0.6 | 60.9 | GO:0016568 | chromatin modification(GO:0016568) |
0.6 | 5.4 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.6 | 7.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.6 | 3.0 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.6 | 1.8 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.6 | 1.2 | GO:0001704 | formation of primary germ layer(GO:0001704) |
0.6 | 24.6 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.6 | 1.2 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.6 | 1.8 | GO:0030323 | respiratory tube development(GO:0030323) |
0.6 | 1.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.6 | 0.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.6 | 5.4 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.6 | 5.3 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.6 | 1.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.6 | 2.4 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.6 | 5.3 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.6 | 0.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.6 | 3.5 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.6 | 4.1 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.6 | 1.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.6 | 1.8 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.6 | 2.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.6 | 0.6 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.6 | 1.7 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.6 | 1.7 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.6 | 0.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.6 | 13.3 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.6 | 0.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 3.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.6 | 1.2 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.6 | 5.2 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.6 | 32.2 | GO:0031497 | chromatin assembly(GO:0031497) |
0.6 | 2.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.6 | 29.9 | GO:0050900 | leukocyte migration(GO:0050900) |
0.6 | 2.9 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.6 | 27.0 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
0.6 | 0.6 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.6 | 27.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.6 | 9.7 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
0.6 | 9.2 | GO:0044247 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.6 | 1.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.6 | 0.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.6 | 0.6 | GO:0006304 | DNA modification(GO:0006304) |
0.6 | 1.7 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.6 | 1.7 | GO:0042180 | cellular ketone metabolic process(GO:0042180) |
0.6 | 3.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.6 | 2.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.6 | 2.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.6 | 9.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 4.0 | GO:0009628 | response to abiotic stimulus(GO:0009628) |
0.6 | 2.3 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.6 | 0.6 | GO:0021675 | nerve development(GO:0021675) |
0.6 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.6 | 5.0 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.6 | 0.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.6 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.6 | 4.5 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.6 | 2.8 | GO:0009268 | response to pH(GO:0009268) |
0.6 | 19.4 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.6 | 0.6 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.6 | 0.6 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.6 | 0.6 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.6 | 2.8 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.6 | 2.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.5 | 9.3 | GO:0015758 | hexose transport(GO:0008645) glucose transport(GO:0015758) |
0.5 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.5 | 1.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.5 | 24.7 | GO:0000279 | M phase(GO:0000279) |
0.5 | 1.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 2.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 0.5 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.5 | 1.1 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.5 | 1.1 | GO:0007617 | mating behavior(GO:0007617) reproductive behavior(GO:0019098) multi-organism reproductive behavior(GO:0044705) |
0.5 | 1.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.5 | 1.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.5 | 0.5 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.5 | 17.4 | GO:0016049 | cell growth(GO:0016049) |
0.5 | 3.3 | GO:0019915 | lipid storage(GO:0019915) |
0.5 | 0.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.5 | 0.5 | GO:0001832 | blastocyst growth(GO:0001832) |
0.5 | 1.6 | GO:0015849 | organic acid transport(GO:0015849) carboxylic acid transport(GO:0046942) |
0.5 | 6.5 | GO:0009057 | macromolecule catabolic process(GO:0009057) |
0.5 | 104.6 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.5 | 2.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.5 | 1.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.5 | 1.1 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.5 | 1.6 | GO:0007567 | parturition(GO:0007567) |
0.5 | 5.4 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.5 | 18.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.5 | 1.1 | GO:0071436 | sodium ion export(GO:0071436) |
0.5 | 40.7 | GO:0006955 | immune response(GO:0006955) |
0.5 | 3.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.5 | 0.5 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.5 | 0.5 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.5 | 1.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.5 | 2.1 | GO:0007507 | heart development(GO:0007507) |
0.5 | 1.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 2.7 | GO:0015904 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.5 | 0.5 | GO:0042311 | vasodilation(GO:0042311) |
0.5 | 6.9 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.5 | 0.5 | GO:0007051 | spindle organization(GO:0007051) |
0.5 | 0.5 | GO:0006301 | postreplication repair(GO:0006301) |
0.5 | 3.7 | GO:0055069 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.5 | 4.7 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.5 | 18.8 | GO:0006959 | humoral immune response(GO:0006959) |
0.5 | 9.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.5 | 62.2 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.5 | 2.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.5 | 0.5 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.5 | 1.6 | GO:0007616 | long-term memory(GO:0007616) |
0.5 | 1.0 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.5 | 3.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.5 | 1.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.5 | 3.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.5 | 17.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.5 | 9.3 | GO:0006302 | double-strand break repair(GO:0006302) |
0.5 | 0.5 | GO:0010594 | regulation of endothelial cell migration(GO:0010594) |
0.5 | 1.5 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.5 | 1.0 | GO:0018195 | peptidyl-arginine modification(GO:0018195) peptidyl-arginine N-methylation(GO:0035246) |
0.5 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.5 | 3.6 | GO:0032200 | telomere maintenance(GO:0000723) telomere organization(GO:0032200) |
0.5 | 1.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.5 | 4.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 2.5 | GO:0006906 | vesicle fusion(GO:0006906) |
0.5 | 1.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.5 | 17.1 | GO:0006260 | DNA replication(GO:0006260) |
0.5 | 2.5 | GO:0070489 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.5 | 1.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.5 | 7.0 | GO:0031638 | zymogen activation(GO:0031638) |
0.5 | 4.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.5 | 0.5 | GO:0032612 | interleukin-1 beta production(GO:0032611) interleukin-1 production(GO:0032612) |
0.5 | 3.0 | GO:0051899 | membrane depolarization(GO:0051899) |
0.5 | 108.2 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.5 | 1.5 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.5 | 1.0 | GO:0001959 | regulation of cytokine-mediated signaling pathway(GO:0001959) |
0.5 | 1.0 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.5 | 0.5 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.5 | 0.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.5 | 44.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.5 | 3.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.5 | 4.9 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.5 | 0.5 | GO:0045851 | pH reduction(GO:0045851) |
0.5 | 4.4 | GO:0030282 | bone mineralization(GO:0030282) |
0.5 | 3.9 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.5 | 1.9 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.5 | 0.5 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.5 | 0.5 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.5 | 0.5 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.5 | 0.5 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.5 | 1.9 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.5 | 4.3 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.5 | 1.4 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.5 | 29.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.5 | 6.7 | GO:0007416 | synapse assembly(GO:0007416) |
0.5 | 1.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.5 | 1.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.5 | 1.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.5 | 1.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.5 | 0.5 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.5 | 3.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.5 | 0.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.5 | 0.5 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) aspartate transport(GO:0015810) |
0.5 | 38.4 | GO:0043632 | modification-dependent macromolecule catabolic process(GO:0043632) |
0.5 | 0.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.5 | 9.9 | GO:0016337 | single organismal cell-cell adhesion(GO:0016337) |
0.5 | 5.2 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.5 | 0.5 | GO:0051238 | sequestering of metal ion(GO:0051238) |
0.5 | 1.9 | GO:0006298 | mismatch repair(GO:0006298) |
0.5 | 3.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.5 | 0.5 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.5 | 0.5 | GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production(GO:1903555) |
0.5 | 3.7 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.5 | 1.9 | GO:0001649 | osteoblast differentiation(GO:0001649) |
0.5 | 9.8 | GO:0051297 | centrosome organization(GO:0051297) |
0.5 | 45.2 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.5 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.5 | 0.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.5 | 0.5 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.5 | 4.6 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.5 | 6.0 | GO:0051302 | regulation of cell division(GO:0051302) |
0.5 | 0.9 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.5 | 0.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.5 | 1.8 | GO:0003143 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.5 | 1.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.5 | 4.1 | GO:0007623 | circadian rhythm(GO:0007623) |
0.5 | 8.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.5 | 444.7 | GO:0006351 | transcription, DNA-templated(GO:0006351) nucleic acid-templated transcription(GO:0097659) |
0.5 | 2.3 | GO:0006997 | nucleus organization(GO:0006997) |
0.5 | 6.3 | GO:0006826 | iron ion transport(GO:0006826) |
0.5 | 0.9 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.4 | 2.2 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
0.4 | 0.4 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 50.2 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.4 | 2.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.4 | 2.7 | GO:0006022 | aminoglycan metabolic process(GO:0006022) |
0.4 | 4.9 | GO:0009791 | post-embryonic development(GO:0009791) |
0.4 | 1.3 | GO:0050890 | cognition(GO:0050890) |
0.4 | 22.4 | GO:0030168 | platelet activation(GO:0030168) |
0.4 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.4 | 2.2 | GO:0032259 | methylation(GO:0032259) |
0.4 | 41.0 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.4 | 0.4 | GO:0032835 | glomerulus development(GO:0032835) |
0.4 | 6.9 | GO:0022900 | electron transport chain(GO:0022900) |
0.4 | 0.4 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.4 | 0.9 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.4 | 2.1 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.4 | 1.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.4 | 2.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.4 | 8.5 | GO:0044772 | mitotic cell cycle phase transition(GO:0044772) |
0.4 | 3.4 | GO:0009615 | response to virus(GO:0009615) |
0.4 | 0.4 | GO:0043405 | regulation of MAP kinase activity(GO:0043405) |
0.4 | 1.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.4 | 8.4 | GO:0048585 | negative regulation of response to stimulus(GO:0048585) |
0.4 | 20.1 | GO:0007601 | visual perception(GO:0007601) |
0.4 | 2.5 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.4 | 1.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.4 | 13.3 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.4 | 1.2 | GO:0006639 | neutral lipid metabolic process(GO:0006638) acylglycerol metabolic process(GO:0006639) |
0.4 | 25.0 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.4 | 0.8 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.4 | 0.4 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.4 | 0.4 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.4 | 3.3 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.4 | 2.9 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.4 | 0.4 | GO:0008361 | regulation of cell size(GO:0008361) |
0.4 | 1.2 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.4 | 1.2 | GO:0034332 | adherens junction organization(GO:0034332) |
0.4 | 2.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 2.0 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
0.4 | 6.5 | GO:0006165 | nucleoside diphosphate phosphorylation(GO:0006165) |
0.4 | 1.6 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.4 | 3.3 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.4 | 1.6 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.4 | 4.9 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.4 | 0.8 | GO:0007034 | vacuolar transport(GO:0007034) |
0.4 | 2.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 8.1 | GO:0007338 | single fertilization(GO:0007338) |
0.4 | 0.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.4 | 7.2 | GO:0008285 | negative regulation of cell proliferation(GO:0008285) |
0.4 | 2.8 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 1.2 | GO:0006818 | hydrogen transport(GO:0006818) |
0.4 | 1.2 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.4 | 11.1 | GO:0006865 | amino acid transport(GO:0006865) |
0.4 | 2.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 19.2 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
0.4 | 0.8 | GO:0002262 | myeloid cell homeostasis(GO:0002262) |
0.4 | 8.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.4 | 19.2 | GO:0006396 | RNA processing(GO:0006396) |
0.4 | 0.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.4 | 0.4 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.4 | 0.8 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) |
0.4 | 11.7 | GO:0044267 | cellular protein metabolic process(GO:0044267) |
0.4 | 1.9 | GO:0010467 | gene expression(GO:0010467) |
0.4 | 2.7 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.4 | 0.8 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.4 | 41.7 | GO:0006813 | potassium ion transport(GO:0006813) |
0.4 | 0.4 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.4 | 1.1 | GO:0001906 | cell killing(GO:0001906) |
0.4 | 5.7 | GO:0007017 | microtubule-based process(GO:0007017) |
0.4 | 0.4 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.4 | 0.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 16.3 | GO:0006457 | protein folding(GO:0006457) |
0.4 | 8.0 | GO:0002376 | immune system process(GO:0002376) |
0.4 | 1.5 | GO:0016358 | dendrite development(GO:0016358) |
0.4 | 3.4 | GO:0007286 | spermatid development(GO:0007286) |
0.4 | 1.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.4 | 0.4 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.4 | 0.4 | GO:0042391 | regulation of membrane potential(GO:0042391) |
0.4 | 1.1 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.4 | 1.8 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.4 | 14.7 | GO:0008283 | cell proliferation(GO:0008283) |
0.4 | 0.7 | GO:0006809 | nitric oxide biosynthetic process(GO:0006809) |
0.4 | 1.8 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.4 | 1.1 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.4 | 111.6 | GO:0006508 | proteolysis(GO:0006508) |
0.4 | 0.7 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.4 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.4 | 1.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 0.4 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.4 | 9.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.4 | 17.0 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.4 | 100.4 | GO:0015031 | protein transport(GO:0015031) |
0.4 | 2.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.4 | 9.1 | GO:0016055 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
0.4 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 5.9 | GO:0061025 | membrane fusion(GO:0061025) |
0.3 | 10.8 | GO:0045087 | innate immune response(GO:0045087) |
0.3 | 1.0 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.3 | 0.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.3 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.3 | 0.3 | GO:0090083 | inclusion body assembly(GO:0070841) regulation of inclusion body assembly(GO:0090083) |
0.3 | 2.1 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.3 | 0.3 | GO:0032868 | response to insulin(GO:0032868) |
0.3 | 5.1 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.3 | 0.7 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.3 | 6.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.3 | 5.9 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.3 | 0.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.3 | 0.9 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.3 | 0.9 | GO:0048753 | pigment granule organization(GO:0048753) |
0.3 | 3.4 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.3 | 1.2 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.3 | 0.3 | GO:0034614 | cellular response to reactive oxygen species(GO:0034614) |
0.3 | 2.1 | GO:0007586 | digestion(GO:0007586) |
0.3 | 3.4 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.3 | 1.2 | GO:0018193 | peptidyl-amino acid modification(GO:0018193) |
0.3 | 0.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 11.5 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.3 | 0.3 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.3 | 2.7 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.3 | 3.5 | GO:0009100 | glycoprotein metabolic process(GO:0009100) |
0.3 | 2.6 | GO:0009887 | organ morphogenesis(GO:0009887) |
0.3 | 0.9 | GO:0070206 | protein trimerization(GO:0070206) |
0.3 | 58.4 | GO:0008219 | cell death(GO:0008219) |
0.3 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.3 | 0.8 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.3 | 3.6 | GO:0007281 | germ cell development(GO:0007281) |
0.3 | 0.6 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.3 | 0.6 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
0.3 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.3 | 0.3 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.3 | 19.0 | GO:0007276 | gamete generation(GO:0007276) |
0.3 | 1.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 0.5 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.3 | 2.8 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.3 | 3.3 | GO:0043010 | camera-type eye development(GO:0043010) |
0.3 | 0.5 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.3 | 2.3 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.3 | 18.5 | GO:0006952 | defense response(GO:0006952) |
0.2 | 0.7 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.2 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 38.8 | GO:0055085 | transmembrane transport(GO:0055085) |
0.2 | 1.9 | GO:0006790 | sulfur compound metabolic process(GO:0006790) |
0.2 | 1.2 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.2 | 3.0 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.2 | 0.7 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.2 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 2.0 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.2 | 24.0 | GO:0016310 | phosphorylation(GO:0016310) |
0.2 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 76.0 | GO:0007165 | signal transduction(GO:0007165) |
0.2 | 2.1 | GO:0007409 | axonogenesis(GO:0007409) |
0.2 | 6.1 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.2 | 0.4 | GO:0042633 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.2 | 0.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.2 | 0.2 | GO:0021510 | spinal cord development(GO:0021510) |
0.2 | 0.2 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.2 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.2 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 0.5 | GO:0043623 | cellular protein complex assembly(GO:0043623) |
0.2 | 0.7 | GO:0007389 | pattern specification process(GO:0007389) |
0.2 | 1.0 | GO:0001503 | ossification(GO:0001503) |
0.2 | 5.0 | GO:0006935 | chemotaxis(GO:0006935) taxis(GO:0042330) |
0.2 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.3 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.2 | 5.3 | GO:0005975 | carbohydrate metabolic process(GO:0005975) |
0.1 | 20.2 | GO:0022610 | biological adhesion(GO:0022610) |
0.1 | 0.1 | GO:0070254 | mucus secretion(GO:0070254) |
0.1 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.1 | 1.3 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.1 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 16.7 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.2 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.1 | 0.4 | GO:0006195 | purine nucleotide catabolic process(GO:0006195) |
0.1 | 0.1 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.1 | 3.0 | GO:0006629 | lipid metabolic process(GO:0006629) |
0.1 | 0.1 | GO:0010817 | regulation of hormone levels(GO:0010817) |
0.1 | 0.8 | GO:0048285 | organelle fission(GO:0048285) |
0.1 | 0.5 | GO:0009790 | embryo development(GO:0009790) |
0.1 | 0.1 | GO:0051726 | regulation of cell cycle(GO:0051726) |
0.1 | 0.1 | GO:0009593 | detection of chemical stimulus(GO:0009593) |
0.1 | 1.5 | GO:0007517 | muscle organ development(GO:0007517) |
0.1 | 0.2 | GO:0051051 | negative regulation of transport(GO:0051051) |
0.1 | 0.1 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 0.1 | GO:0090066 | regulation of anatomical structure size(GO:0090066) |
0.0 | 0.1 | GO:0033043 | regulation of organelle organization(GO:0033043) |
0.0 | 0.0 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 2.4 | GO:0006811 | ion transport(GO:0006811) |
0.0 | 0.0 | GO:0000278 | mitotic cell cycle(GO:0000278) |
0.0 | 0.5 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 10.7 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.0 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.0 | GO:0031667 | response to nutrient levels(GO:0031667) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.6 | 22.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
3.4 | 10.2 | GO:0072487 | MSL complex(GO:0072487) |
2.9 | 8.6 | GO:0044462 | external encapsulating structure part(GO:0044462) |
2.8 | 8.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.7 | 8.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.7 | 2.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.6 | 7.9 | GO:0070820 | tertiary granule(GO:0070820) |
2.6 | 7.9 | GO:0032009 | early phagosome(GO:0032009) |
2.4 | 9.7 | GO:0043218 | compact myelin(GO:0043218) |
2.4 | 9.5 | GO:0005667 | transcription factor complex(GO:0005667) |
2.4 | 2.4 | GO:0070938 | contractile ring(GO:0070938) |
2.4 | 2.4 | GO:0032432 | actin filament bundle(GO:0032432) |
2.3 | 16.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
2.3 | 11.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.2 | 6.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
2.2 | 15.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
2.1 | 8.4 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
2.1 | 6.2 | GO:0031904 | endosome lumen(GO:0031904) |
2.1 | 20.5 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
2.0 | 2.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.9 | 5.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.9 | 1.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.9 | 5.7 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
1.9 | 9.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.9 | 26.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.9 | 16.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.9 | 13.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.8 | 14.7 | GO:0005861 | troponin complex(GO:0005861) |
1.8 | 7.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
1.8 | 7.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.8 | 12.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.8 | 8.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.7 | 13.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
1.7 | 6.7 | GO:0005827 | polar microtubule(GO:0005827) |
1.7 | 6.7 | GO:0042587 | glycogen granule(GO:0042587) |
1.7 | 5.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.7 | 35.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
1.7 | 28.2 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
1.6 | 9.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.6 | 4.9 | GO:0005915 | zonula adherens(GO:0005915) |
1.6 | 9.8 | GO:0005883 | neurofilament(GO:0005883) |
1.6 | 6.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.6 | 4.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.6 | 11.3 | GO:0034451 | centriolar satellite(GO:0034451) |
1.6 | 1.6 | GO:0012505 | endomembrane system(GO:0012505) |
1.6 | 12.6 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
1.6 | 33.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.6 | 31.3 | GO:0031519 | PcG protein complex(GO:0031519) |
1.5 | 18.4 | GO:0031528 | microvillus membrane(GO:0031528) |
1.5 | 7.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.5 | 3.0 | GO:0031012 | extracellular matrix(GO:0031012) |
1.5 | 16.4 | GO:0001772 | immunological synapse(GO:0001772) |
1.5 | 4.4 | GO:0071437 | invadopodium(GO:0071437) |
1.5 | 5.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.5 | 14.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.5 | 5.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
1.5 | 5.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.4 | 4.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.4 | 4.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
1.4 | 8.4 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
1.4 | 9.6 | GO:0005840 | ribosome(GO:0005840) |
1.4 | 5.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.4 | 4.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.4 | 4.1 | GO:0000124 | SAGA complex(GO:0000124) |
1.4 | 1.4 | GO:0044306 | neuron projection terminus(GO:0044306) |
1.4 | 5.4 | GO:0070552 | BRISC complex(GO:0070552) |
1.3 | 8.1 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
1.3 | 8.0 | GO:0001891 | phagocytic cup(GO:0001891) |
1.3 | 4.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.3 | 5.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.3 | 3.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.3 | 9.2 | GO:0043209 | myelin sheath(GO:0043209) |
1.3 | 29.9 | GO:0032153 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
1.3 | 2.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.3 | 6.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.3 | 7.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.3 | 3.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.3 | 2.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.3 | 6.4 | GO:0034464 | BBSome(GO:0034464) |
1.2 | 13.7 | GO:0071564 | npBAF complex(GO:0071564) |
1.2 | 3.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.2 | 5.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.2 | 3.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.2 | 11.2 | GO:0042555 | MCM complex(GO:0042555) |
1.2 | 6.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.2 | 4.8 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
1.2 | 97.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.2 | 2.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
1.2 | 5.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.2 | 3.5 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
1.2 | 4.7 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
1.2 | 9.3 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.2 | 10.4 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
1.1 | 9.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.1 | 3.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
1.1 | 5.7 | GO:0045179 | apical cortex(GO:0045179) |
1.1 | 1.1 | GO:0044216 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
1.1 | 29.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.1 | 6.7 | GO:0042382 | paraspeckles(GO:0042382) |
1.1 | 17.7 | GO:0031252 | cell leading edge(GO:0031252) |
1.1 | 8.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.1 | 2.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.1 | 3.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.1 | 18.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
1.1 | 21.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.1 | 8.5 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
1.1 | 1.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
1.1 | 75.1 | GO:0030027 | lamellipodium(GO:0030027) |
1.1 | 2.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.0 | 1.0 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
1.0 | 4.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.0 | 10.4 | GO:0042588 | zymogen granule(GO:0042588) |
1.0 | 8.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.0 | 2.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.0 | 13.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.0 | 3.1 | GO:0032059 | bleb(GO:0032059) |
1.0 | 4.1 | GO:0043005 | neuron projection(GO:0043005) |
1.0 | 1.0 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
1.0 | 2.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.0 | 2.0 | GO:0031932 | TORC2 complex(GO:0031932) |
1.0 | 2.0 | GO:0030008 | TRAPP complex(GO:0030008) |
1.0 | 35.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.0 | 3.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
1.0 | 14.1 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
1.0 | 25.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.0 | 7.0 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
1.0 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.0 | 5.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 3.0 | GO:0043083 | synaptic cleft(GO:0043083) |
1.0 | 6.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
1.0 | 32.6 | GO:0030496 | midbody(GO:0030496) |
1.0 | 3.0 | GO:0055037 | recycling endosome(GO:0055037) |
1.0 | 20.6 | GO:0005776 | autophagosome(GO:0005776) |
1.0 | 3.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.0 | 4.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.0 | 7.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.0 | 44.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.0 | 1.0 | GO:0005839 | proteasome core complex(GO:0005839) |
1.0 | 2.9 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.9 | 7.6 | GO:0044291 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.9 | 4.7 | GO:0000805 | X chromosome(GO:0000805) |
0.9 | 2.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.9 | 15.0 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.9 | 6.6 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.9 | 30.9 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.9 | 11.2 | GO:0032039 | integrator complex(GO:0032039) |
0.9 | 3.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.9 | 2.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.9 | 5.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.9 | 1.9 | GO:0038201 | TOR complex(GO:0038201) |
0.9 | 4.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.9 | 3.7 | GO:0030315 | T-tubule(GO:0030315) |
0.9 | 9.1 | GO:0030057 | desmosome(GO:0030057) |
0.9 | 17.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.9 | 3.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.9 | 1.8 | GO:0000800 | lateral element(GO:0000800) |
0.9 | 68.5 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.9 | 5.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.9 | 9.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.9 | 2.7 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) clathrin adaptor complex(GO:0030131) |
0.9 | 8.0 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.9 | 2.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.9 | 6.2 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.9 | 95.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.9 | 3.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.9 | 18.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.9 | 9.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.9 | 15.0 | GO:0030018 | Z disc(GO:0030018) |
0.9 | 1.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.9 | 0.9 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.9 | 7.0 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.9 | 187.7 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.9 | 9.6 | GO:0005694 | chromosome(GO:0005694) |
0.9 | 2.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.9 | 4.3 | GO:0000791 | euchromatin(GO:0000791) |
0.9 | 106.1 | GO:0005819 | spindle(GO:0005819) |
0.9 | 3.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.9 | 8.5 | GO:0030175 | filopodium(GO:0030175) |
0.8 | 43.9 | GO:0005813 | centrosome(GO:0005813) |
0.8 | 5.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.8 | 92.0 | GO:0030424 | axon(GO:0030424) |
0.8 | 2.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.8 | 14.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.8 | 8.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.8 | 29.9 | GO:0031256 | leading edge membrane(GO:0031256) |
0.8 | 14.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.8 | 11.6 | GO:0005844 | polysome(GO:0005844) |
0.8 | 11.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.8 | 14.8 | GO:0031526 | brush border membrane(GO:0031526) |
0.8 | 0.8 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 15.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.8 | 59.7 | GO:0012506 | vesicle membrane(GO:0012506) |
0.8 | 4.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.8 | 4.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.8 | 24.4 | GO:0016592 | mediator complex(GO:0016592) |
0.8 | 17.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.8 | 46.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.8 | 2.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.8 | 1.6 | GO:0001652 | granular component(GO:0001652) |
0.8 | 11.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.8 | 25.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.8 | 17.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.8 | 6.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.8 | 64.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.8 | 38.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.8 | 54.0 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.8 | 11.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.8 | 1.5 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.8 | 18.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.8 | 1.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 3.0 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.7 | 15.0 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.7 | 6.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.7 | 12.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.7 | 121.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.7 | 37.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.7 | 58.7 | GO:0005769 | early endosome(GO:0005769) |
0.7 | 3.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.7 | 197.6 | GO:0000139 | Golgi membrane(GO:0000139) |
0.7 | 27.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.7 | 1.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.7 | 2.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 2.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.7 | 5.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.7 | 157.6 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.7 | 7.1 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.7 | 28.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.7 | 2870.6 | GO:0005634 | nucleus(GO:0005634) |
0.7 | 2.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.7 | 2.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.7 | 10.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.7 | 0.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.7 | 13.3 | GO:0005768 | endosome(GO:0005768) |
0.7 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 486.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.6 | 12.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.6 | 51.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 7.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.6 | 9.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.6 | 181.8 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.6 | 83.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.6 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 1.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.6 | 347.3 | GO:0005829 | cytosol(GO:0005829) |
0.6 | 10.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.6 | 6.1 | GO:0032420 | stereocilium(GO:0032420) |
0.5 | 8.2 | GO:0072372 | primary cilium(GO:0072372) |
0.5 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.5 | 71.5 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.5 | 1.6 | GO:0030426 | growth cone(GO:0030426) site of polarized growth(GO:0030427) |
0.5 | 2.1 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.5 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 4.6 | GO:0031090 | organelle membrane(GO:0031090) |
0.5 | 8.5 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 10.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.5 | 281.4 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.5 | 5.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 1.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 16.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.5 | 12.7 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.5 | 1.4 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.4 | 3.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 932.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.4 | 441.4 | GO:0005737 | cytoplasm(GO:0005737) |
0.4 | 41.1 | GO:0071944 | cell periphery(GO:0071944) |
0.3 | 0.6 | GO:0009986 | cell surface(GO:0009986) |
0.3 | 0.3 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 115.7 | GO:0005622 | intracellular(GO:0005622) |
0.2 | 3.0 | GO:0005929 | cilium(GO:0005929) |
0.2 | 1.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.2 | GO:0097458 | neuron part(GO:0097458) |
0.2 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 6.9 | GO:0016020 | membrane(GO:0016020) |
0.1 | 0.4 | GO:0005792 | obsolete microsome(GO:0005792) |
0.1 | 2.5 | GO:0043234 | protein complex(GO:0043234) |
0.1 | 58.4 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 27.7 | GO:0005615 | extracellular space(GO:0005615) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
4.0 | 12.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
3.9 | 11.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
3.7 | 14.9 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
3.6 | 14.4 | GO:0031014 | troponin T binding(GO:0031014) |
3.6 | 14.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
3.5 | 10.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
3.4 | 3.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
3.2 | 9.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
3.2 | 9.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
3.2 | 9.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
3.1 | 18.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.0 | 3.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
3.0 | 9.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
2.9 | 11.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.8 | 8.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.8 | 8.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.7 | 11.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.7 | 8.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.7 | 2.7 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
2.7 | 2.7 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
2.7 | 8.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.6 | 10.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
2.6 | 31.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
2.6 | 5.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
2.5 | 7.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
2.5 | 12.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.5 | 7.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
2.5 | 12.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
2.5 | 7.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.4 | 7.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
2.4 | 7.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.4 | 19.4 | GO:0050700 | CARD domain binding(GO:0050700) |
2.4 | 7.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.4 | 2.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
2.4 | 4.8 | GO:0015254 | glycerol channel activity(GO:0015254) |
2.3 | 16.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
2.3 | 13.9 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
2.3 | 9.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
2.3 | 6.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.3 | 6.8 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
2.3 | 6.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.3 | 13.5 | GO:0070888 | E-box binding(GO:0070888) |
2.2 | 6.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
2.2 | 19.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
2.2 | 8.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.2 | 10.9 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
2.2 | 2.2 | GO:0033691 | sialic acid binding(GO:0033691) |
2.2 | 8.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
2.2 | 6.5 | GO:0035197 | siRNA binding(GO:0035197) |
2.1 | 12.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
2.1 | 4.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
2.1 | 8.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
2.1 | 16.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
2.1 | 10.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
2.1 | 6.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.1 | 10.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.0 | 6.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
2.0 | 24.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
2.0 | 14.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
2.0 | 8.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
2.0 | 6.0 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.0 | 20.1 | GO:0030276 | clathrin binding(GO:0030276) |
2.0 | 6.0 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
2.0 | 4.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
2.0 | 7.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
2.0 | 5.9 | GO:0050693 | LBD domain binding(GO:0050693) |
2.0 | 2.0 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
2.0 | 9.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.9 | 9.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.9 | 7.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.9 | 5.8 | GO:0030172 | troponin C binding(GO:0030172) |
1.9 | 11.5 | GO:0051400 | BH domain binding(GO:0051400) |
1.9 | 20.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.9 | 22.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.9 | 5.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.9 | 5.6 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
1.9 | 9.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.9 | 7.4 | GO:0016208 | AMP binding(GO:0016208) |
1.8 | 9.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.8 | 5.5 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
1.8 | 10.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.8 | 18.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
1.8 | 5.4 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
1.8 | 3.6 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
1.8 | 10.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
1.8 | 3.6 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
1.8 | 8.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.8 | 7.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
1.8 | 12.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.8 | 5.3 | GO:0043398 | HLH domain binding(GO:0043398) |
1.8 | 5.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.8 | 5.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.8 | 17.6 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
1.8 | 31.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.7 | 7.0 | GO:0048495 | Roundabout binding(GO:0048495) |
1.7 | 5.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.7 | 15.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.7 | 27.9 | GO:0043621 | protein self-association(GO:0043621) |
1.7 | 3.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.7 | 10.4 | GO:0030371 | translation repressor activity(GO:0030371) |
1.7 | 6.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
1.7 | 12.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.7 | 5.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.7 | 5.1 | GO:0045569 | TRAIL binding(GO:0045569) |
1.7 | 1.7 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
1.7 | 8.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.7 | 5.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
1.7 | 1.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
1.7 | 6.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.7 | 5.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.7 | 8.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
1.7 | 10.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.7 | 1.7 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.7 | 16.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.7 | 6.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.7 | 8.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.7 | 6.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
1.7 | 8.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.7 | 78.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.7 | 58.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.7 | 1.7 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
1.7 | 29.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.7 | 34.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.7 | 5.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
1.6 | 4.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.6 | 27.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.6 | 4.9 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
1.6 | 4.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.6 | 4.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.6 | 6.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.6 | 1.6 | GO:0000975 | regulatory region DNA binding(GO:0000975) regulatory region nucleic acid binding(GO:0001067) transcription regulatory region DNA binding(GO:0044212) |
1.6 | 4.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.6 | 12.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.6 | 12.8 | GO:0005112 | Notch binding(GO:0005112) |
1.6 | 4.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 6.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
1.6 | 6.3 | GO:0015925 | galactosidase activity(GO:0015925) |
1.6 | 4.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.6 | 7.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.6 | 4.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.6 | 6.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.5 | 7.7 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
1.5 | 3.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.5 | 3.1 | GO:0005035 | death receptor activity(GO:0005035) |
1.5 | 10.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.5 | 13.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
1.5 | 9.1 | GO:0005521 | lamin binding(GO:0005521) |
1.5 | 7.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.5 | 6.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.5 | 15.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.5 | 6.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.5 | 6.0 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
1.5 | 3.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.5 | 11.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.5 | 5.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.5 | 4.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
1.5 | 2.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
1.5 | 4.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.5 | 23.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.5 | 4.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.4 | 8.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.4 | 14.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
1.4 | 2.9 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
1.4 | 5.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.4 | 14.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.4 | 5.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.4 | 7.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.4 | 17.0 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
1.4 | 4.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.4 | 1.4 | GO:0046790 | virion binding(GO:0046790) |
1.4 | 2.8 | GO:0032451 | demethylase activity(GO:0032451) |
1.4 | 4.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.4 | 2.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.4 | 6.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.4 | 9.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
1.4 | 5.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.4 | 6.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.4 | 5.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.4 | 11.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.4 | 8.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.4 | 5.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
1.4 | 10.9 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.4 | 1.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.4 | 6.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.4 | 5.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.4 | 5.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.4 | 19.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
1.4 | 8.2 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
1.4 | 4.1 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
1.4 | 8.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.3 | 14.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.3 | 4.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 2.7 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
1.3 | 9.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.3 | 9.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.3 | 10.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
1.3 | 5.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.3 | 5.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.3 | 7.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.3 | 7.9 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
1.3 | 3.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.3 | 2.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.3 | 9.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.3 | 3.9 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.3 | 3.9 | GO:0016972 | thiol oxidase activity(GO:0016972) |
1.3 | 3.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.3 | 3.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.3 | 3.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
1.3 | 3.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.3 | 1.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.3 | 6.5 | GO:0005497 | androgen binding(GO:0005497) |
1.3 | 1.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.3 | 14.1 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
1.3 | 6.4 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.3 | 3.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.3 | 14.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.3 | 10.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.3 | 1.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
1.3 | 30.5 | GO:0016504 | peptidase activator activity(GO:0016504) |
1.3 | 99.0 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
1.3 | 15.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
1.3 | 6.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
1.3 | 3.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
1.3 | 8.8 | GO:0003785 | actin monomer binding(GO:0003785) |
1.3 | 26.3 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
1.3 | 1.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.3 | 5.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.2 | 23.7 | GO:0050699 | WW domain binding(GO:0050699) |
1.2 | 5.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.2 | 31.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.2 | 4.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.2 | 7.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.2 | 8.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.2 | 19.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.2 | 4.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.2 | 3.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.2 | 1.2 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
1.2 | 2.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.2 | 3.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.2 | 2.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.2 | 7.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
1.2 | 5.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.2 | 5.9 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
1.2 | 2.4 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.2 | 3.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.2 | 2.4 | GO:0004875 | complement receptor activity(GO:0004875) |
1.2 | 3.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.2 | 2.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.2 | 4.6 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
1.2 | 17.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.2 | 4.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.2 | 2.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.1 | 4.6 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
1.1 | 2.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
1.1 | 5.7 | GO:0004568 | chitinase activity(GO:0004568) |
1.1 | 43.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.1 | 20.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
1.1 | 10.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
1.1 | 4.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.1 | 4.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
1.1 | 2.2 | GO:0001846 | opsonin binding(GO:0001846) |
1.1 | 4.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.1 | 4.5 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
1.1 | 1.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
1.1 | 1.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
1.1 | 4.4 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
1.1 | 7.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.1 | 2.2 | GO:0005113 | patched binding(GO:0005113) |
1.1 | 6.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
1.1 | 3.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.1 | 3.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 6.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.1 | 2.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
1.1 | 1.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.1 | 2.2 | GO:0031404 | chloride ion binding(GO:0031404) |
1.1 | 12.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
1.1 | 1.1 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
1.1 | 5.3 | GO:0030332 | cyclin binding(GO:0030332) |
1.1 | 4.2 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
1.1 | 4.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
1.1 | 4.2 | GO:0070402 | NADPH binding(GO:0070402) |
1.1 | 7.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.1 | 2.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.1 | 4.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.0 | 4.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.0 | 3.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.0 | 3.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
1.0 | 3.1 | GO:0008061 | chitin binding(GO:0008061) |
1.0 | 4.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.0 | 4.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.0 | 9.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.0 | 4.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.0 | 1.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.0 | 4.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.0 | 3.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.0 | 2.0 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
1.0 | 11.2 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
1.0 | 232.2 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
1.0 | 4.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.0 | 3.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
1.0 | 6.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.0 | 17.2 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.0 | 2.0 | GO:0031013 | troponin I binding(GO:0031013) |
1.0 | 7.0 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.0 | 2.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.0 | 2.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.0 | 5.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.0 | 5.0 | GO:0004904 | interferon receptor activity(GO:0004904) |
1.0 | 2.0 | GO:0042806 | fucose binding(GO:0042806) |
1.0 | 6.9 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.0 | 4.9 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
1.0 | 2.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.0 | 3.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
1.0 | 6.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.0 | 3.9 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.0 | 1.9 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.0 | 14.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
1.0 | 7.8 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
1.0 | 8.7 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
1.0 | 15.4 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
1.0 | 24.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
1.0 | 1.9 | GO:0019211 | phosphatase activator activity(GO:0019211) |
1.0 | 14.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.0 | 26.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
1.0 | 8.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.9 | 5.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.9 | 13.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.9 | 2.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.9 | 4.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.9 | 5.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.9 | 23.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.9 | 1.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 6.5 | GO:0005522 | profilin binding(GO:0005522) |
0.9 | 0.9 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) peptide-transporting ATPase activity(GO:0015440) |
0.9 | 2.8 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.9 | 3.7 | GO:0001848 | complement binding(GO:0001848) |
0.9 | 3.7 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.9 | 2.7 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.9 | 1.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.9 | 0.9 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.9 | 93.3 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.9 | 9.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.9 | 0.9 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.9 | 9.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.9 | 84.7 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.9 | 13.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.9 | 3.6 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.9 | 3.6 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.9 | 3.6 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.9 | 3.6 | GO:0005534 | galactose binding(GO:0005534) |
0.9 | 41.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.9 | 0.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.9 | 3.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.9 | 0.9 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.9 | 0.9 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.9 | 2.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.9 | 2.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.9 | 4.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.9 | 4.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.9 | 6.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.9 | 4.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.9 | 5.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 2.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.9 | 21.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.9 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.9 | 4.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.9 | 4.4 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.9 | 0.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.9 | 2.6 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.9 | 4.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.9 | 2.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.9 | 3.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.9 | 2.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.9 | 9.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.9 | 7.8 | GO:0030515 | snoRNA binding(GO:0030515) |
0.9 | 0.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.9 | 5.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.9 | 3.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.9 | 1.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.9 | 10.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.9 | 3.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.9 | 3.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.9 | 10.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.9 | 2.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.9 | 6.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.9 | 17.9 | GO:0019003 | GDP binding(GO:0019003) |
0.9 | 2.6 | GO:0019863 | IgE binding(GO:0019863) |
0.9 | 5.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.9 | 2.6 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.8 | 1.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.8 | 12.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.8 | 56.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.8 | 29.6 | GO:0042393 | histone binding(GO:0042393) |
0.8 | 267.8 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.8 | 2.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 2.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.8 | 2.5 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.8 | 10.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.8 | 2.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.8 | 5.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.8 | 5.0 | GO:0008430 | selenium binding(GO:0008430) |
0.8 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.8 | 10.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.8 | 9.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.8 | 8.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.8 | 8.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.8 | 9.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.8 | 5.0 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.8 | 3.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.8 | 32.8 | GO:0008017 | microtubule binding(GO:0008017) |
0.8 | 0.8 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.8 | 1.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 4.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.8 | 4.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.8 | 28.6 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.8 | 5.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.8 | 3.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.8 | 5.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.8 | 5.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.8 | 17.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.8 | 7.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.8 | 3.2 | GO:0004340 | glucokinase activity(GO:0004340) |
0.8 | 4.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.8 | 8.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.8 | 4.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.8 | 6.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.8 | 0.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.8 | 8.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.8 | 3.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 2.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.8 | 4.0 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.8 | 19.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.8 | 4.0 | GO:0009374 | biotin binding(GO:0009374) |
0.8 | 7.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.8 | 3.9 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.8 | 190.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.8 | 6.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.8 | 3.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.8 | 1.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.8 | 10.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.8 | 1.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.8 | 3.1 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.8 | 2.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.8 | 5.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.8 | 10.8 | GO:0051117 | ATPase binding(GO:0051117) |
0.8 | 6.2 | GO:0019864 | IgG binding(GO:0019864) |
0.8 | 2.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.8 | 1.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.8 | 15.4 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.8 | 2.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 2.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 3.0 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.8 | 3.8 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.8 | 3.8 | GO:0015288 | porin activity(GO:0015288) |
0.8 | 14.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.8 | 4.5 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.7 | 21.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.7 | 12.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.7 | 3.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.7 | 3.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.7 | 9.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.7 | 6.7 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.7 | 1.5 | GO:0016744 | transketolase activity(GO:0004802) transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.7 | 3.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 1.5 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.7 | 22.8 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.7 | 16.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.7 | 2.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.7 | 24.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.7 | 8.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.7 | 10.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.7 | 0.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.7 | 5.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.7 | 2.2 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.7 | 10.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.7 | 5.0 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.7 | 13.7 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.7 | 13.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.7 | 1.4 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.7 | 1.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.7 | 2.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
0.7 | 2.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 1.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.7 | 2.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.7 | 0.7 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.7 | 4.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.7 | 22.6 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.7 | 4.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.7 | 7.0 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.7 | 1.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.7 | 3.5 | GO:0031432 | titin binding(GO:0031432) |
0.7 | 3.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.7 | 24.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.7 | 1.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.7 | 0.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.7 | 15.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.7 | 10.3 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
0.7 | 4.8 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.7 | 3.4 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.7 | 24.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.7 | 8.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.7 | 0.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.7 | 45.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.7 | 4.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.7 | 0.7 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.7 | 19.0 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.7 | 7.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.7 | 17.5 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.7 | 11.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.7 | 2.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.7 | 3.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.7 | 48.4 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.7 | 11.4 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.7 | 30.0 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.7 | 46.3 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.7 | 2.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.7 | 9.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.7 | 12.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.7 | 2.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.7 | 2.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.7 | 7.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.7 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 1.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.7 | 2.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.7 | 15.7 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.7 | 2.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.7 | 20.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.7 | 2.0 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.6 | 6.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.6 | 1.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.6 | 1.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.6 | 3.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.6 | 3.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.6 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.6 | 1.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 7.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.6 | 24.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.6 | 725.9 | GO:0003677 | DNA binding(GO:0003677) |
0.6 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.6 | 5.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.6 | 1.9 | GO:0016595 | glutamate binding(GO:0016595) |
0.6 | 2.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.6 | 1.9 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.6 | 1.9 | GO:0008252 | nucleotidase activity(GO:0008252) 5'-nucleotidase activity(GO:0008253) |
0.6 | 0.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.6 | 3.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.6 | 1.2 | GO:0016907 | acetylcholine receptor activity(GO:0015464) G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.6 | 3.1 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.6 | 1.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.6 | 1.8 | GO:0070513 | death domain binding(GO:0070513) |
0.6 | 0.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 4.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.6 | 1.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 3.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.6 | 2.4 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.6 | 153.0 | GO:0005525 | GTP binding(GO:0005525) |
0.6 | 1.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.6 | 101.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.6 | 1.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 1.2 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
0.6 | 1.2 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 9.9 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.6 | 1.2 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 1.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.6 | 1.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.6 | 4.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.6 | 2.9 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.6 | 3.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.6 | 9.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.6 | 1.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.6 | 7.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.6 | 1.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.6 | 1.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.6 | 5.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.6 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.6 | 14.3 | GO:0003823 | antigen binding(GO:0003823) |
0.6 | 3.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 4.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.6 | 1.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.6 | 9.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 7.3 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.6 | 2.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 3.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.6 | 1.7 | GO:0043531 | ADP binding(GO:0043531) |
0.6 | 2.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.6 | 0.6 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.6 | 1.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.6 | 1.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.5 | 1.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 1.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 376.2 | GO:0008270 | zinc ion binding(GO:0008270) |
0.5 | 0.5 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.5 | 7.6 | GO:0019905 | syntaxin binding(GO:0019905) |
0.5 | 6.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 6.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.5 | 2.7 | GO:0022884 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
0.5 | 18.4 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.5 | 1.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.5 | 6.5 | GO:0051020 | GTPase binding(GO:0051020) |
0.5 | 10.2 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.5 | 1.6 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.5 | 4.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.5 | 11.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.5 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.5 | 4.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 3.2 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.5 | 4.2 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.5 | 11.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.5 | 10.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.5 | 16.8 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.5 | 7.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.5 | 38.8 | GO:0005267 | potassium channel activity(GO:0005267) |
0.5 | 13.1 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.5 | 2.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.5 | 4.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 1.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.5 | 2.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.5 | 72.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.5 | 11.3 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.5 | 1.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 163.7 | GO:0003723 | RNA binding(GO:0003723) |
0.5 | 3.6 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.5 | 65.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.5 | 3.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 1.5 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.5 | 7.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.5 | 14.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.5 | 2.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 2.0 | GO:0052650 | alcohol dehydrogenase (NADP+) activity(GO:0008106) NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 9.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 3.4 | GO:0019209 | kinase activator activity(GO:0019209) |
0.5 | 2.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 3.4 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.5 | 1.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.5 | 23.5 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.5 | 14.4 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.5 | 3.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.5 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.5 | 1.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.5 | 14.7 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.5 | 1.4 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.5 | 2.4 | GO:0016462 | pyrophosphatase activity(GO:0016462) |
0.5 | 5.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.5 | 1.9 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.5 | 8.9 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.5 | 2.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 1.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) thiamine pyrophosphate binding(GO:0030976) |
0.5 | 3.7 | GO:0016877 | ligase activity, forming carbon-sulfur bonds(GO:0016877) |
0.5 | 25.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.5 | 0.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.5 | 3.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 1.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.5 | 1.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 1.8 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.5 | 1.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 9.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.5 | 5.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 7.2 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.4 | 21.4 | GO:0019900 | kinase binding(GO:0019900) |
0.4 | 3.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.4 | 2.7 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.4 | 1.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 2.7 | GO:0016859 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) cis-trans isomerase activity(GO:0016859) |
0.4 | 1.3 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.4 | 1.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 1.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.4 | 0.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.4 | 64.4 | GO:0005125 | cytokine activity(GO:0005125) |
0.4 | 1.7 | GO:0035240 | dopamine binding(GO:0035240) |
0.4 | 13.0 | GO:0004871 | signal transducer activity(GO:0004871) |
0.4 | 0.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.4 | 2.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 33.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 2.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.4 | 4.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 1.3 | GO:0005549 | odorant binding(GO:0005549) |
0.4 | 0.8 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.4 | 2.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.4 | 0.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 2.4 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.4 | 0.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 2.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 5.7 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.4 | 0.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.4 | 1.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.4 | 8.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.4 | 5.2 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.4 | 2.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 1.2 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.4 | 11.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 2.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 0.8 | GO:0005048 | signal sequence binding(GO:0005048) |
0.4 | 3.5 | GO:0051287 | NAD binding(GO:0051287) |
0.4 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 26.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.4 | 0.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 3.0 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.4 | 0.7 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 0.7 | GO:0015926 | glucosidase activity(GO:0015926) |
0.4 | 5.2 | GO:0003774 | motor activity(GO:0003774) |
0.4 | 10.7 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.4 | 5.5 | GO:0016829 | lyase activity(GO:0016829) |
0.4 | 1.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 11.7 | GO:0004518 | nuclease activity(GO:0004518) |
0.4 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 1.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.4 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.4 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 0.4 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 822.6 | GO:0005515 | protein binding(GO:0005515) |
0.4 | 2.1 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.4 | 7.7 | GO:0050662 | coenzyme binding(GO:0050662) |
0.3 | 6.6 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.3 | 5.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 0.7 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.3 | 78.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.3 | 2.0 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.3 | 0.6 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.3 | 0.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 217.1 | GO:0005488 | binding(GO:0005488) |
0.3 | 0.8 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.3 | 2.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 1.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 2.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.3 | 1.0 | GO:0015250 | water channel activity(GO:0015250) |
0.3 | 0.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 3.7 | GO:0015297 | antiporter activity(GO:0015297) |
0.2 | 5.8 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.2 | 31.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.2 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 2.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.2 | 0.4 | GO:0016817 | hydrolase activity, acting on acid anhydrides(GO:0016817) |
0.2 | 88.9 | GO:0060089 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.2 | 0.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 16.7 | GO:0016787 | hydrolase activity(GO:0016787) |
0.1 | 0.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.1 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 3.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.3 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 3.5 | GO:0005215 | transporter activity(GO:0005215) |
0.0 | 0.0 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 8.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
2.5 | 160.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
2.2 | 22.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.2 | 2.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.1 | 40.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.1 | 16.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.0 | 36.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.9 | 27.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.8 | 59.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.8 | 18.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.8 | 37.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.7 | 17.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.7 | 8.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.7 | 11.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.6 | 8.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.6 | 9.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.6 | 22.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.6 | 3.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
1.5 | 23.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.5 | 27.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.4 | 47.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.4 | 21.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.4 | 17.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.4 | 32.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.4 | 12.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.4 | 64.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.4 | 5.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.4 | 36.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.4 | 13.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.4 | 26.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.4 | 22.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.4 | 24.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.4 | 5.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.4 | 16.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.3 | 25.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.3 | 41.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.3 | 5.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.3 | 28.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.3 | 1.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
1.3 | 29.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.3 | 10.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.3 | 25.9 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.3 | 7.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.3 | 71.7 | PID P73PATHWAY | p73 transcription factor network |
1.2 | 7.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.2 | 7.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.2 | 19.9 | PID FOXO PATHWAY | FoxO family signaling |
1.2 | 33.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.2 | 7.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.2 | 9.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.2 | 27.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
1.2 | 2.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.2 | 6.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.2 | 5.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.2 | 28.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
1.1 | 7.8 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.1 | 42.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.1 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.1 | 12.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.1 | 23.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.1 | 7.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.1 | 14.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.1 | 4.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.1 | 3.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.1 | 30.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.0 | 4.2 | PID ALK2 PATHWAY | ALK2 signaling events |
1.0 | 5.2 | PID CDC42 PATHWAY | CDC42 signaling events |
1.0 | 14.5 | ST GAQ PATHWAY | G alpha q Pathway |
1.0 | 4.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.0 | 21.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.0 | 13.2 | PID BCR 5PATHWAY | BCR signaling pathway |
1.0 | 4.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.0 | 13.1 | PID ARF6 PATHWAY | Arf6 signaling events |
1.0 | 24.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.0 | 4.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.0 | 29.9 | PID PLK1 PATHWAY | PLK1 signaling events |
1.0 | 14.9 | PID AURORA A PATHWAY | Aurora A signaling |
1.0 | 19.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.0 | 13.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.0 | 29.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.9 | 7.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.9 | 1.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.9 | 9.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.9 | 13.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 1.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.9 | 6.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.9 | 19.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.9 | 6.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.9 | 3.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.9 | 7.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.9 | 7.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.9 | 5.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.9 | 10.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.9 | 16.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.9 | 14.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 4.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.8 | 10.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.8 | 24.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.8 | 0.8 | PID MYC PATHWAY | C-MYC pathway |
0.8 | 18.8 | PID FGF PATHWAY | FGF signaling pathway |
0.8 | 12.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.8 | 0.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.8 | 21.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.8 | 8.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.8 | 10.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.8 | 6.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.8 | 8.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.8 | 15.3 | PID ATM PATHWAY | ATM pathway |
0.8 | 31.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.8 | 12.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.8 | 19.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.7 | 21.0 | PID BMP PATHWAY | BMP receptor signaling |
0.7 | 29.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.7 | 15.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.7 | 35.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.7 | 15.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.7 | 9.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.7 | 7.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.7 | 4.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.7 | 9.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.7 | 2.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.7 | 3.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.6 | 6.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 11.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.6 | 3.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.6 | 17.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.6 | 2.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.6 | 1.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 4.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 16.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 2.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 6.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 9.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.5 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.5 | 3.6 | ST ADRENERGIC | Adrenergic Pathway |
0.5 | 4.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.5 | 2.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.5 | 2.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.5 | 2.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.4 | 5.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 2.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 6.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.4 | 3.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.4 | 1.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 1.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 7.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.4 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 5.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.4 | 65.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 1.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.4 | 3.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 6.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 0.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.3 | 3.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 3.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 2.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 2.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 2.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.3 | 2.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 2.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 4.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.3 | 0.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 7.0 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 0.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 1.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.3 | 2.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 3.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 7.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 9.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 4.9 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 45.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 6.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 3.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 19.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 5.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
4.5 | 4.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
3.4 | 6.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
3.1 | 37.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
3.0 | 33.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
2.9 | 23.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
2.8 | 2.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
2.3 | 18.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.2 | 68.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
2.1 | 6.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
2.1 | 6.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
2.1 | 16.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
2.0 | 38.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.0 | 6.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
2.0 | 20.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.9 | 29.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.9 | 5.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.9 | 53.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.8 | 21.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.8 | 28.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.8 | 3.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
1.7 | 7.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.7 | 14.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.7 | 20.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.7 | 22.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.7 | 30.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.7 | 58.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.7 | 1.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
1.6 | 11.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.6 | 53.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.6 | 17.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.6 | 1.6 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
1.6 | 20.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.5 | 15.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.5 | 12.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.5 | 16.4 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.5 | 5.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.5 | 21.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.4 | 13.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.4 | 4.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.4 | 7.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.4 | 4.2 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
1.4 | 31.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.4 | 31.6 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.4 | 16.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
1.4 | 17.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
1.4 | 6.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.3 | 1.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
1.3 | 2.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.3 | 40.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.3 | 44.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.3 | 22.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.3 | 11.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.3 | 16.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.3 | 2.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.3 | 14.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.3 | 5.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
1.3 | 15.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.3 | 16.5 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
1.3 | 15.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.2 | 3.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.2 | 10.0 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.2 | 23.5 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.2 | 22.0 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
1.2 | 19.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.2 | 18.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.2 | 7.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.2 | 4.6 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.2 | 2.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.2 | 12.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.1 | 6.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.1 | 11.4 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.1 | 28.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.1 | 23.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.1 | 3.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.1 | 2.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.1 | 16.5 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
1.1 | 11.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.1 | 22.8 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.1 | 5.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.1 | 4.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
1.1 | 10.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.1 | 14.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.1 | 8.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.1 | 24.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.1 | 18.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.1 | 6.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.1 | 5.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.1 | 58.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.1 | 11.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.1 | 9.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.1 | 11.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.0 | 10.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.0 | 11.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.0 | 24.7 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.0 | 25.7 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.0 | 10.3 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.0 | 19.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.0 | 1.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
1.0 | 7.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.0 | 24.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.0 | 15.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.0 | 14.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.0 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
1.0 | 31.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.0 | 68.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.0 | 4.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.0 | 4.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.0 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.0 | 4.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.0 | 11.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 17.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.0 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.0 | 1.9 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
1.0 | 16.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.0 | 15.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.0 | 14.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.9 | 11.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.9 | 5.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.9 | 8.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 12.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.9 | 11.7 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.9 | 26.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.9 | 11.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.9 | 2.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.9 | 9.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.9 | 79.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.9 | 15.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.9 | 42.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.9 | 5.2 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.9 | 1.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.9 | 6.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.9 | 2.6 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.8 | 17.8 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.8 | 6.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.8 | 8.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.8 | 65.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.8 | 16.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.8 | 11.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 10.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.8 | 4.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.8 | 5.7 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.8 | 13.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.8 | 11.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.8 | 11.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.8 | 20.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.8 | 66.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.8 | 2.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.8 | 5.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.8 | 27.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.8 | 27.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.8 | 25.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.8 | 19.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 9.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.8 | 26.3 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.7 | 5.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.7 | 23.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.7 | 22.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.7 | 1.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.7 | 2.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.7 | 13.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.7 | 9.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.7 | 6.4 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
0.7 | 38.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.7 | 9.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.7 | 16.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.7 | 3.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 4.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.7 | 4.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.7 | 14.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.7 | 5.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.7 | 175.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.7 | 34.1 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.7 | 0.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.7 | 2.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.7 | 16.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.7 | 37.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.6 | 1.3 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.6 | 8.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 4.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.6 | 10.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.6 | 1.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.6 | 6.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.6 | 5.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 9.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.6 | 8.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.6 | 3.0 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.6 | 1.2 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.6 | 6.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.6 | 5.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.6 | 7.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.6 | 66.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.6 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.6 | 21.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.6 | 11.0 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.6 | 9.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.6 | 28.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.6 | 5.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 26.5 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.6 | 8.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 4.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.6 | 7.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 1.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.6 | 27.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 3.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.6 | 5.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.6 | 4.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.6 | 8.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.5 | 9.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 8.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 5.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 5.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.5 | 15.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.5 | 3.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.5 | 19.1 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.5 | 5.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.5 | 7.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 3.7 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.5 | 6.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.5 | 25.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 0.5 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.5 | 2.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.5 | 2.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.5 | 1.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.5 | 7.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.5 | 6.3 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 9.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 25.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.5 | 41.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 4.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 44.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.4 | 22.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 1.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.4 | 17.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 5.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 2.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.4 | 17.3 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.4 | 7.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 5.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 0.4 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.4 | 32.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 13.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.4 | 10.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 8.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.4 | 13.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.4 | 4.0 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.4 | 2.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 3.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 9.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.4 | 13.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 4.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.4 | 7.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 4.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.4 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 4.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 0.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 0.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.3 | 4.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.3 | 4.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 13.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 1.3 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
0.3 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.3 | 5.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 2.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.3 | 1.9 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.3 | 7.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 1.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 0.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 3.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 0.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.3 | 2.6 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.3 | 5.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 11.8 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 0.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 3.3 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.2 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.6 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 2.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.6 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.1 | 0.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.7 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 2.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 13.2 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |